Value Set eHDSIActiveIngredient

Value Set eHDSIActiveIngredient 2021‑04‑19 15:45:00

1.3.6.1.4.1.12559.11.10.1.3.1.42.24

Effective Date

2021‑04‑19 15:45:00

Status

Final

Version Label

202104

Name

eHDSIActiveIngredient

Display Name

eHDSIActiveIngredient

Description

The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.

Source Code System

2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: urn:oid:2.16.840.1.113883.6.73

Level/ Type	Code	Display Name	Code System
0‑L	A	ALIMENTARY TRACT AND METABOLISM	WHO Anatomical Therapeutic Chemical classification
0‑L	A01	STOMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A01A	STOMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA	Caries prophylactic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA01	sodium fluoride	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA02	sodium monofluorophosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA03	olaflur	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA04	stannous fluoride	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA51	sodium fluoride, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB	Antiinfectives and antiseptics for local oral treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB02	hydrogen peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB03	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB04	amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB05	polynoxylin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB06	domiphen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB07	oxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB08	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB09	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB10	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB11	various	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB12	hexetidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB13	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB14	benzoxonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB15	tibezonium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB16	mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB17	metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB18	clotrimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB19	sodium perborate	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB21	chlortetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB22	doxycycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB23	minocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC	Corticosteroids for local oral treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC01	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC02	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC03	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC54	prednisolone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD	Other agents for local oral treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD01	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD02	benzydamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD05	acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD06	adrenalone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD07	amlexanox	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD08	becaplermin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD11	various	WHO Anatomical Therapeutic Chemical classification
0‑L	A02	DRUGS FOR ACID RELATED DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A02A	ANTACIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA	Magnesium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA01	magnesium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA02	magnesium oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA03	magnesium peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA04	magnesium hydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA05	magnesium silicate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB	Aluminium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB01	aluminium hydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB02	algeldrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB03	aluminium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB04	dihydroxialumini sodium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB05	aluminium acetoacetate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB06	aloglutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB07	aluminium glycinate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC	Calcium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC01	calcium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC02	calcium silicate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD	Combinations and complexes of aluminium, calcium and magnesium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD01	ordinary salt combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD02	magaldrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD03	almagate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD04	hydrotalcite	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD05	almasilate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF	Antacids with antiflatulents	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF01	magaldrate and antiflatulents	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF02	ordinary salt combinations and antiflatulents	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AG	Antacids with antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AH	Antacids with sodium bicarbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AX	Antacids, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA	H2-receptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA01	cimetidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA02	ranitidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA03	famotidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA04	nizatidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA05	niperotidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA06	roxatidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA07	ranitidine bismuth citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA08	lafutidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA51	cimetidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA53	famotidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB	Prostaglandins	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB01	misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB02	enprostil	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC	Proton pump inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC01	omeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC02	pantoprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC03	lansoprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC04	rabeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC05	esomeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC06	dexlansoprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC07	dexrabeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC08	vonoprazan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC53	lansoprazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC54	rabeprazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD	Combinations for eradication of Helicobacter pylori	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD01	omeprazole, amoxicillin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD02	lansoprazole, tetracycline and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD03	lansoprazole, amoxicillin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD04	pantoprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD05	omeprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD06	esomeprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD07	lansoprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD08	bismuth subcitrate, tetracycline and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD09	lansoprazole, clarithromycin and tinidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD10	lansoprazole, amoxicillin and levofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD11	pantoprazole, amoxicillin, clarithromycin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD12	rabeprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD13	rabeprazole, amoxicillin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD14	vonoprazan, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD15	vonoprazan, amoxicillin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX01	carbenoxolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX02	sucralfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX03	pirenzepine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX04	methiosulfonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX05	bismuth subcitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX06	proglumide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX07	gefarnate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX08	sulglicotide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX09	acetoxolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX10	zolimidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX11	troxipide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX12	bismuth subnitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX13	alginic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX14	rebamipide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX51	carbenoxolone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX71	carbenoxolone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX77	gefarnate, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02X	OTHER DRUGS FOR ACID RELATED DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03	DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03A	DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA	Synthetic anticholinergics, esters with tertiary amino group	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA01	oxyphencyclimine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA03	camylofin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA04	mebeverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA05	trimebutine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA06	rociverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA07	dicycloverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA08	dihexyverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA09	difemerine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA30	piperidolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB	Synthetic anticholinergics, quaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB01	benzilone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB02	glycopyrronium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB03	oxyphenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB04	penthienate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB05	propantheline	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB06	otilonium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB07	methantheline	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB08	tridihexethyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB09	isopropamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB10	hexocyclium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB11	poldine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB12	mepenzolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB13	bevonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB14	pipenzolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB15	diphemanil	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB16	(2-benzhydryloxyethyl)diethyl-methylammonium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB17	tiemonium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB18	prifinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB19	timepidium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB21	fenpiverinium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB53	oxyphenonium, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC	Synthetic antispasmodics, amides with tertiary amines	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC02	dimethylaminopropionylphenothiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC04	nicofetamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC05	tiropramide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD	Papaverine and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD01	papaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD02	drotaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD30	moxaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE	Serotonin receptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE01	alosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE03	cilansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX	Other drugs for functional gastrointestinal disorders	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX01	fenpiprane	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX02	diisopromine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX03	chlorbenzoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX04	pinaverium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX05	fenoverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX06	idanpramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX07	proxazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX08	alverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX09	trepibutone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX10	isometheptene	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX11	caroverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX12	phloroglucinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX13	silicones	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX14	valethamate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX15	menthae piperitae aetheroleum	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX30	trimethyldiphenylpropylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX58	alverine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A03B	BELLADONNA AND DERIVATIVES, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA	Belladonna alkaloids, tertiary amines	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA01	atropine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA03	hyoscyamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA04	belladonna total alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB	Belladonna alkaloids, semisynthetic, quaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB01	butylscopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB02	methylatropine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB03	methylscopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB04	fentonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB05	cimetropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB06	homatropine methylbromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03C	ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA	Synthetic anticholinergic agents in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA01	isopropamide and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA02	clidinium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA03	oxyphencyclimine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA04	otilonium bromide and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA05	glycopyrronium bromide and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA06	bevonium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA07	ambutonium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA08	diphemanil and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA09	pipenzolate and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA30	emepronium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA34	propantheline and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB	Belladonna and derivatives in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB01	methylscopolamine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB02	belladonna total alkaloids and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB03	atropine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB04	homatropine methylbromide and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB31	hyoscyamine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CC	Other antispasmodics in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03D	ANTISPASMODICS IN COMBINATION WITH ANALGESICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA	Synthetic anticholinergic agents in combination with analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA01	tropenzilone and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA02	pitofenone and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA03	bevonium and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA04	ciclonium and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA05	camylofin and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA06	trospium and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA07	tiemonium iodide and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB	Belladonna and derivatives in combination with analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB04	butylscopolamine and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DC	Other antispasmodics in combination with analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03E	ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03EA	Antispasmodics, psycholeptics and analgesics in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A03ED	Antispasmodics in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A03F	PROPULSIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA	Propulsives	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA01	metoclopramide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA02	cisapride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA03	domperidone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA04	bromopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA05	alizapride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA06	clebopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA07	itopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA08	cinitapride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA09	mosapride	WHO Anatomical Therapeutic Chemical classification
0‑L	A04	ANTIEMETICS AND ANTINAUSEANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A04A	ANTIEMETICS AND ANTINAUSEANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA	Serotonin (5HT3) antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA01	ondansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA02	granisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA03	tropisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA04	dolasetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA05	palonosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA55	palonosetron, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD	Other antiemetics	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD01	scopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD02	cerium oxalate	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD04	chlorobutanol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD05	metopimazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD10	dronabinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD11	nabilone	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD12	aprepitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD13	casopitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD14	rolapitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD51	scopolamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD54	chlorobutanol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A05	BILE AND LIVER THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	A05A	BILE THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA	Bile acids and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA01	chenodeoxycholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA02	ursodeoxycholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA03	cholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA04	obeticholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB	Preparations for biliary tract therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB01	nicotinyl methylamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX	Other drugs for bile therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX01	piprozolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX02	hymecromone	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX03	cyclobutyrol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05B	LIVER THERAPY, LIPOTROPICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA	Liver therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA01	arginine glutamate	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA03	silymarin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA04	citiolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA05	epomediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA06	ornithine oxoglurate	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA07	tidiacic arginine	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA08	glycyrrhizic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA09	metadoxine	WHO Anatomical Therapeutic Chemical classification
0‑L	A05C	DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	A06	DRUGS FOR CONSTIPATION	WHO Anatomical Therapeutic Chemical classification
0‑L	A06A	DRUGS FOR CONSTIPATION	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA	Softeners, emollients	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA01	liquid paraffin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA02	docusate sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA51	liquid paraffin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB	Contact laxatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB01	oxyphenisatine	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB02	bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB03	dantron	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB04	phenolphthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB05	castor oil	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB06	senna glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB07	cascara	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB08	sodium picosulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB09	bisoxatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB20	contact laxatives in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB30	contact laxatives in combination with belladonna alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB52	bisacodyl, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB53	dantron, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB56	senna glycosides, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB57	cascara, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB58	sodium picosulfate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC	Bulk-forming laxatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC01	ispaghula (psylla seeds)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC02	ethulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC03	sterculia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC05	linseed	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC06	methylcellulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC07	triticum (wheat fibre)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC08	polycarbophil calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC51	ispaghula, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC53	sterculia, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC55	linseed, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD	Osmotically acting laxatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD01	magnesium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD02	magnesium oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD03	magnesium peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD04	magnesium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD10	mineral salts in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD11	lactulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD12	lactitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD13	sodium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD14	pentaerithrityl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD15	macrogol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD16	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD17	sodium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD18	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD19	magnesium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD21	sodium tartrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD61	lactulose, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD65	macrogol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG	Enemas	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG01	sodium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG02	bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG03	dantron, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG04	glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG06	oil	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG07	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG10	docusate sodium, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG11	sodium lauryl sulfoacetate, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH	Peripheral opioid receptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH01	methylnaltrexone bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH02	alvimopan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH03	naloxegol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH04	naloxone	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH05	naldemedine	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX	Other drugs for constipation	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX01	glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX02	carbon dioxide producing drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX03	lubiprostone	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX04	linaclotide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX05	prucalopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX06	tegaserod	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX07	plecanatide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX08	tenapanor	WHO Anatomical Therapeutic Chemical classification
0‑L	A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07A	INTESTINAL ANTIINFECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA01	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA02	nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA03	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA04	streptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA05	polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA06	paromomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA07	amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA08	kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA09	vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA10	colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA11	rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA12	fidaxomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA13	rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA51	neomycin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA54	streptomycin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB	Sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB02	phthalylsulfathiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB03	sulfaguanidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB04	succinylsulfathiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC	Imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC01	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX	Other intestinal antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX01	broxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX02	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX03	nifuroxazide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX04	nifurzide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07B	INTESTINAL ADSORBENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA	Charcoal preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA01	medicinal charcoal	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA51	medicinal charcoal, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BB	Bismuth preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC	Other intestinal adsorbents	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC01	pectin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC02	kaolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC03	crospovidone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC04	attapulgite	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC05	diosmectite	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC54	attapulgite, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07C	ELECTROLYTES WITH CARBOHYDRATES	WHO Anatomical Therapeutic Chemical classification
0‑L	A07CA	Oral rehydration salt formulations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07D	ANTIPROPULSIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA	Antipropulsives	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA01	diphenoxylate	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA02	opium	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA03	loperamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA04	difenoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA05	loperamide oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA06	eluxadoline	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA52	morphine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA53	loperamide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07E	INTESTINAL ANTIINFLAMMATORY AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA	Corticosteroids acting locally	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA01	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA02	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA03	prednisone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA04	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA05	tixocortol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA06	budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA07	beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB	Antiallergic agents, excl. corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB01	cromoglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC	Aminosalicylic acid and similar agents	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC01	sulfasalazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC02	mesalazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC03	olsalazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC04	balsalazide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07F	ANTIDIARRHEAL MICROORGANISMS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA	Antidiarrheal microorganisms	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA01	lactic acid producing organisms	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA02	saccharomyces boulardii	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA51	lactic acid producing organisms, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07X	OTHER ANTIDIARRHEALS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA	Other antidiarrheals	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA01	albumin tannate	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA02	ceratonia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA03	calcium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA04	racecadotril	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA06	crofelemer	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA51	albumin tannate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A08	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A08A	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA	Centrally acting antiobesity products	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA01	phentermine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA02	fenfluramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA03	amfepramone	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA04	dexfenfluramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA05	mazindol	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA06	etilamfetamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA07	cathine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA08	clobenzorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA09	mefenorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA10	sibutramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA11	lorcaserin	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA56	ephedrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA62	bupropion and naltrexone	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB	Peripherally acting antiobesity products	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB01	orlistat	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AX	Other antiobesity drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AX01	rimonabant	WHO Anatomical Therapeutic Chemical classification
0‑L	A09	DIGESTIVES, INCL. ENZYMES	WHO Anatomical Therapeutic Chemical classification
0‑L	A09A	DIGESTIVES, INCL. ENZYMES	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA	Enzyme preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA01	diastase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA02	multienzymes (lipase, protease etc.)	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA03	pepsin	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA04	tilactase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB	Acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB01	glutamic acid hydrochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB02	betaine hydrochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB03	hydrochloric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB04	citric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC	Enzyme and acid preparations, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC01	pepsin and acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC02	multienzymes and acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10	DRUGS USED IN DIABETES	WHO Anatomical Therapeutic Chemical classification
0‑L	A10A	INSULINS AND ANALOGUES	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB	Insulins and analogues for injection, fast-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB04	insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB05	insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB06	insulin glulisine	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC	Insulins and analogues for injection, intermediate-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC04	insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD	Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD04	insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD05	insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD06	insulin degludec and insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE	Insulins and analogues for injection, long-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE04	insulin glargine	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE05	insulin detemir	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE06	insulin degludec	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE54	insulin glargine and lixisenatide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE56	insulin degludec and liraglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF	Insulins and analogues for inhalation	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA	Biguanides	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA01	phenformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA02	metformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA03	buformin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB	Sulfonylureas	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB01	glibenclamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB02	chlorpropamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB03	tolbutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB04	glibornuride	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB05	tolazamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB06	carbutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB07	glipizide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB08	gliquidone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB09	gliclazide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB10	metahexamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB11	glisoxepide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB12	glimepiride	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB31	acetohexamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BC	Sulfonamides (heterocyclic)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BC01	glymidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD	Combinations of oral blood glucose lowering drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD01	phenformin and sulfonylureas	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD02	metformin and sulfonylureas	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD03	metformin and rosiglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD04	glimepiride and rosiglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD05	metformin and pioglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD06	glimepiride and pioglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD07	metformin and sitagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD08	metformin and vildagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD09	pioglitazone and alogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD10	metformin and saxagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD11	metformin and linagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD12	pioglitazone and sitagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD13	metformin and alogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD14	metformin and repaglinide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD15	metformin and dapagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD16	metformin and canagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD17	metformin and acarbose	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD18	metformin and gemigliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD19	linagliptin and empagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD20	metformin and empagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD21	saxagliptin and dapagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD22	metformin and evogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD23	metformin and ertugliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD24	sitagliptin and ertugliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD25	metformin, saxagliptin and dapagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD26	metformin and lobeglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF	Alpha glucosidase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF01	acarbose	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF02	miglitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF03	voglibose	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG	Thiazolidinediones	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG01	troglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG02	rosiglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG03	pioglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG04	lobeglitazone	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH	Dipeptidyl peptidase 4 (DPP-4) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH01	sitagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH02	vildagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH03	saxagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH04	alogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH05	linagliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH06	gemigliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH07	evogliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH08	teneligliptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH51	sitagliptin and simvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH52	gemigliptin and rosuvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ	Glucagon-like peptide-1 (GLP-1) analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ01	exenatide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ02	liraglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ03	lixisenatide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ04	albiglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ05	dulaglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ06	semaglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ07	beinaglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK	Sodium-glucose co-transporter 2 (SGLT2) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK01	dapagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK02	canagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK03	empagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK04	ertugliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK05	ipragliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK06	sotagliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK07	luseogliflozin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX	Other blood glucose lowering drugs, excl. insulins	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX01	guar gum	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX02	repaglinide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX03	nateglinide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX05	pramlintide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX06	benfluorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX08	mitiglinide	WHO Anatomical Therapeutic Chemical classification
0‑L	A10X	OTHER DRUGS USED IN DIABETES	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XA	Aldose reductase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XA01	tolrestat	WHO Anatomical Therapeutic Chemical classification
0‑L	A11	VITAMINS	WHO Anatomical Therapeutic Chemical classification
0‑L	A11A	MULTIVITAMINS, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA	Multivitamins with minerals	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA01	multivitamins and iron	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA02	multivitamins and calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA03	multivitamins and other minerals, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA04	multivitamins and trace elements	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AB	Multivitamins, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11B	MULTIVITAMINS, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A11BA	Multivitamins, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	A11C	VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA	Vitamin A, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA01	retinol (vit A)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA02	betacarotene	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CB	Vitamin A and D in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC	Vitamin D and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC01	ergocalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC02	dihydrotachysterol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC03	alfacalcidol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC04	calcitriol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC05	colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC06	calcifediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC55	colecalciferol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11D	VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA	Vitamin B1, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA01	thiamine (vit B1)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA02	sulbutiamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA03	benfotiamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DB	Vitamin B1 in combination with vitamin B6 and/or vitamin B12	WHO Anatomical Therapeutic Chemical classification
0‑L	A11E	VITAMIN B-COMPLEX, INCL. COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EA	Vitamin B-complex, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EB	Vitamin B-complex with vitamin C	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EC	Vitamin B-complex with minerals	WHO Anatomical Therapeutic Chemical classification
0‑L	A11ED	Vitamin B-complex with anabolic steroids	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EX	Vitamin B-complex, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11G	ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GA	Ascorbic acid (vitamin C), plain	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GA01	ascorbic acid (vit C)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GB	Ascorbic acid (vitamin C), combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GB01	ascorbic acid (vit C) and calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A11H	OTHER PLAIN VITAMIN PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA	Other plain vitamin preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA01	nicotinamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA02	pyridoxine (vit B6)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA03	tocopherol (vit E)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA04	riboflavin (vit B2)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA05	biotin	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA06	pyridoxal phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA07	inositol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA08	tocofersolan	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA30	dexpanthenol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA31	calcium pantothenate	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA32	pantethine	WHO Anatomical Therapeutic Chemical classification
0‑L	A11J	OTHER VITAMIN PRODUCTS, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JA	Combinations of vitamins	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JB	Vitamins with minerals	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JC	Vitamins, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A12	MINERAL SUPPLEMENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A12A	CALCIUM	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA	Calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA01	calcium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA02	calcium glubionate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA03	calcium gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA04	calcium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA05	calcium lactate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA06	calcium lactate gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA07	calcium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA08	calcium glycerylphosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA09	calcium citrate lysine complex	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA10	calcium glucoheptonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA11	calcium pangamate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA13	calcium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA20	calcium (different salts in combination)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA30	calcium laevulate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AX	Calcium, combinations with vitamin D and/or other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A12B	POTASSIUM	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA	Potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA01	potassium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA02	potassium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA03	potassium hydrogentartrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA04	potassium hydrogencarbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA05	potassium gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA30	potassium (different salts in combination)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA51	potassium chloride, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A12C	OTHER MINERAL SUPPLEMENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA	Sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA01	sodium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA02	sodium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB	Zinc	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB01	zinc sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB02	zinc gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB03	zinc protein complex	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC	Magnesium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC01	magnesium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC02	magnesium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC03	magnesium gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC04	magnesium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC05	magnesium aspartate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC06	magnesium lactate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC07	magnesium levulinate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC08	magnesium pidolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC09	magnesium orotate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC10	magnesium oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC30	magnesium (different salts in combination)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD	Fluoride	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD01	sodium fluoride	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD02	sodium monofluorophosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD51	fluoride, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE	Selenium	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE01	sodium selenate	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE02	sodium selenite	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CX	Other mineral products	WHO Anatomical Therapeutic Chemical classification
0‑L	A13	TONICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A13A	TONICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A14	ANABOLIC AGENTS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	A14A	ANABOLIC STEROIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA	Androstan derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA01	androstanolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA02	stanozolol	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA03	metandienone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA04	metenolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA05	oxymetholone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA06	quinbolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA07	prasterone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA08	oxandrolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA09	norethandrolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB	Estren derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB01	nandrolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB02	ethylestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB03	oxabolone cipionate	WHO Anatomical Therapeutic Chemical classification
0‑L	A14B	OTHER ANABOLIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A15	APPETITE STIMULANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A16	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A16A	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA	Amino acids and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA01	levocarnitine	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA02	ademetionine	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA03	glutamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA04	mercaptamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA05	carglumic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA06	betaine	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA07	metreleptin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB	Enzymes	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB01	alglucerase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB02	imiglucerase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB03	agalsidase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB04	agalsidase beta	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB05	laronidase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB06	sacrosidase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB07	alglucosidase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB08	galsulfase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB09	idursulfase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB10	velaglucerase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB11	taliglucerase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB12	elosulfase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB13	asfotase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB14	sebelipase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB15	velmanase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB16	idursulfase beta	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB17	cerliponase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB18	vestronidase alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB19	pegvaliase	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX	Various alimentary tract and metabolism products	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX01	thioctic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX02	anethole trithione	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX03	sodium phenylbutyrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX04	nitisinone	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX05	zinc acetate	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX06	miglustat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX07	sapropterin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX08	teduglutide	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX09	glycerol phenylbutyrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX10	eliglustat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX11	sodium benzoate	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX12	trientine	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX13	uridine triacetate	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX14	migalastat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX15	telotristat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX16	givosiran	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX17	triheptanoin	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX18	lumasiran	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX30	sodium benzoate and sodium phenylacetate	WHO Anatomical Therapeutic Chemical classification
0‑L	B	BLOOD AND BLOOD FORMING ORGANS	WHO Anatomical Therapeutic Chemical classification
0‑L	B01	ANTITHROMBOTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	B01A	ANTITHROMBOTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA	Vitamin K antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA01	dicoumarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA02	phenindione	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA03	warfarin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA04	phenprocoumon	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA07	acenocoumarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA08	ethyl biscoumacetate	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA09	clorindione	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA10	diphenadione	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA11	tioclomarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA12	fluindione	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB	Heparin group	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB01	heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB02	antithrombin III	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB04	dalteparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB05	enoxaparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB06	nadroparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB07	parnaparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB08	reviparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB09	danaparoid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB10	tinzaparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB11	sulodexide	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB12	bemiparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB51	heparin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC	Platelet aggregation inhibitors excl. heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC01	ditazole	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC02	cloricromen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC03	picotamide	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC04	clopidogrel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC05	ticlopidine	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC06	acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC07	dipyridamole	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC08	carbasalate calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC09	epoprostenol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC10	indobufen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC11	iloprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC13	abciximab	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC15	aloxiprin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC16	eptifibatide	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC17	tirofiban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC18	triflusal	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC19	beraprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC21	treprostinil	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC22	prasugrel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC23	cilostazol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC24	ticagrelor	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC25	cangrelor	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC26	vorapaxar	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC27	selexipag	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC56	acetylsalicylic acid, combinations with proton pump inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD	Enzymes	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD01	streptokinase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD02	alteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD03	anistreplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD04	urokinase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD05	fibrinolysin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD06	brinase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD07	reteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD08	saruplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD09	ancrod	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD10	drotrecogin alfa (activated)	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD11	tenecteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD12	protein C	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE	Direct thrombin inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE01	desirudin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE02	lepirudin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE03	argatroban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE04	melagatran	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE05	ximelagatran	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE06	bivalirudin	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE07	dabigatran etexilate	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF	Direct factor Xa inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF01	rivaroxaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF02	apixaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF03	edoxaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF04	betrixaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX	Other antithrombotic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX01	defibrotide	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX04	dermatan sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX05	fondaparinux	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX07	caplacizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B02	ANTIHEMORRHAGICS	WHO Anatomical Therapeutic Chemical classification
0‑L	B02A	ANTIFIBRINOLYTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA	Amino acids	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA01	aminocaproic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA02	tranexamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA03	aminomethylbenzoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB	Proteinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB01	aprotinin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB02	alfa1 antitrypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB04	camostat	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB05	ulinastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02B	VITAMIN K AND OTHER HEMOSTATICS	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA	Vitamin K	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA01	phytomenadione	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA02	menadione	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BB	Fibrinogen	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BB01	fibrinogen, human	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC	Local hemostatics	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC01	absorbable gelatin sponge	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC02	oxidized cellulose	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC03	tetragalacturonic acid hydroxymethylester	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC05	adrenalone	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC06	thrombin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC07	collagen	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC08	calcium alginate	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC09	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD	Blood coagulation factors	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD01	coagulation factor IX, II, VII and X in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD02	coagulation factor VIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD03	factor VIII inhibitor bypassing activity	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD04	coagulation factor IX	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD05	coagulation factor VII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD06	von Willebrand factor and coagulation factor VIII in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD07	coagulation factor XIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD08	coagulation factor VIIa	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD10	von Willebrand factor	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD11	catridecacog	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD13	coagulation factor X	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD14	susoctocog alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD30	thrombin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX	Other systemic hemostatics	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX01	etamsylate	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX02	carbazochrome	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX03	batroxobin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX04	romiplostim	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX05	eltrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX06	emicizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX07	lusutrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX08	avatrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX09	fostamatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	B03	ANTIANEMIC PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	B03A	IRON PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA	Iron bivalent, oral preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA01	ferrous glycine sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA02	ferrous fumarate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA03	ferrous gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA04	ferrous carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA05	ferrous chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA06	ferrous succinate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA07	ferrous sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA08	ferrous tartrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA09	ferrous aspartate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA10	ferrous ascorbate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA11	ferrous iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA12	ferrous sodium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB	Iron trivalent, oral preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB01	ferric sodium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB02	saccharated iron oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB03	sodium feredetate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB04	ferric hydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB05	ferric oxide polymaltose complexes	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB07	chondroitin sulfate-iron complex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB08	ferric acetyl transferrin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB09	ferric proteinsuccinylate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB10	ferric maltol	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC	Iron, parenteral preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD	Iron in combination with folic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD01	ferrous amino acid complex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD02	ferrous fumarate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD03	ferrous sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD04	ferric oxide polymaltose complexes	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD05	ferrous gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE	Iron in other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE01	iron, vitamin B12 and folic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE02	iron, multivitamins and folic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE03	iron and multivitamins	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE04	iron, multivitamins and minerals	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE10	various combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03B	VITAMIN B12 AND FOLIC ACID	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA	Vitamin B12 (cyanocobalamin and analogues)	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA01	cyanocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA02	cyanocobalamin tannin complex	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA03	hydroxocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA04	cobamamide	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA05	mecobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA51	cyanocobalamin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA53	hydroxocobalamin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB	Folic acid and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB01	folic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB51	folic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03X	OTHER ANTIANEMIC PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA	Other antianemic preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA01	erythropoietin	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA02	darbepoetin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA03	methoxy polyethylene glycol-epoetin beta	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA04	peginesatide	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA05	roxadustat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA06	luspatercept	WHO Anatomical Therapeutic Chemical classification
0‑L	B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	B05A	BLOOD AND RELATED PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA	Blood substitutes and plasma protein fractions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA01	albumin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA02	other plasma protein fractions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA03	fluorocarbon blood substitutes	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA05	dextran	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA06	gelatin agents	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA07	hydroxyethylstarch	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA08	hemoglobin crosfumaril	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA09	hemoglobin raffimer	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA10	hemoglobin glutamer (bovine)	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX	Other blood products	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX01	erythrocytes	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX02	thrombocytes	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX03	blood plasma	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX04	stem cells from umbilical cord blood	WHO Anatomical Therapeutic Chemical classification
0‑L	B05B	I.V. SOLUTIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA	Solutions for parenteral nutrition	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA01	amino acids	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA02	fat emulsions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA03	carbohydrates	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA04	protein hydrolysates	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB	Solutions affecting the electrolyte balance	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB01	electrolytes	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB02	electrolytes with carbohydrates	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB03	trometamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB04	electrolytes in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC	Solutions producing osmotic diuresis	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC01	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC02	carbamide	WHO Anatomical Therapeutic Chemical classification
0‑L	B05C	IRRIGATING SOLUTIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA	Antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA01	cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA02	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA03	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA04	sulfamethizole	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA05	taurolidine	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA06	mandelic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA07	noxytiolin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA08	ethacridine lactate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA09	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB	Salt solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB01	sodium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB02	sodium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB03	magnesium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB04	sodium bicarbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX	Other irrigating solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX01	glucose	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX02	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX03	glycine	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX04	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B05D	PERITONEAL DIALYTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	B05DA	Isotonic solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05DB	Hypertonic solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05X	I.V. SOLUTION ADDITIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA	Electrolyte solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA01	potassium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA02	sodium bicarbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA03	sodium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA04	ammonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA05	magnesium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA06	potassium phosphate, incl. combinations with other potassium salts	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA07	calcium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA08	sodium acetate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA09	sodium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA10	magnesium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA11	magnesium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA12	zinc chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA13	hydrochloric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA14	sodium glycerophosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA15	potassium lactate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA16	cardioplegia solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA17	potassium acetate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA18	zinc sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA30	combinations of electrolytes	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA31	electrolytes in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB	Amino acids	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB01	arginine hydrochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB02	alanyl glutamine	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB03	lysine	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XC	Vitamins	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XX	Other i.v. solution additives	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XX02	trometamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05Z	HEMODIALYTICS AND HEMOFILTRATES	WHO Anatomical Therapeutic Chemical classification
0‑L	B05ZA	Hemodialytics, concentrates	WHO Anatomical Therapeutic Chemical classification
0‑L	B05ZB	Hemofiltrates	WHO Anatomical Therapeutic Chemical classification
0‑L	B06	OTHER HEMATOLOGICAL AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	B06A	OTHER HEMATOLOGICAL AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA	Enzymes	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA02	fibrinolysin and desoxyribonuclease	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA03	hyaluronidase	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA04	chymotrypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA07	trypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA10	desoxyribonuclease	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA55	streptokinase, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AB	Heme products	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AB01	hemin	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC	Drugs used in hereditary angioedema	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC01	c1-inhibitor, plasma derived	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC02	icatibant	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC03	ecallantide	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC04	conestat alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC05	lanadelumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX	Other hematological agents	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX01	crizanlizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX02	betibeglogene autotemcel	WHO Anatomical Therapeutic Chemical classification
0‑L	C	CARDIOVASCULAR SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	C01	CARDIAC THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	C01A	CARDIAC GLYCOSIDES	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA	Digitalis glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA01	acetyldigitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA02	acetyldigoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA03	digitalis leaves	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA04	digitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA05	digoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA06	lanatoside C	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA07	deslanoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA08	metildigoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA09	gitoformate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA52	acetyldigoxin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB	Scilla glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB01	proscillaridin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB51	proscillaridin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC	Strophanthus glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC01	g-strophanthin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC03	cymarin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AX	Other cardiac glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AX02	peruvoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C01B	ANTIARRHYTHMICS, CLASS I AND III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA	Antiarrhythmics, class Ia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA01	quinidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA02	procainamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA03	disopyramide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA04	sparteine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA05	ajmaline	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA08	prajmaline	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA12	lorajmine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA13	hydroquinidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA51	quinidine, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA71	quinidine, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB	Antiarrhythmics, class Ib	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB01	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB02	mexiletine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB03	tocainide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB04	aprindine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC	Antiarrhythmics, class Ic	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC03	propafenone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC04	flecainide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC07	lorcainide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC08	encainide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC09	ethacizine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD	Antiarrhythmics, class III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD01	amiodarone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD02	bretylium tosilate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD03	bunaftine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD04	dofetilide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD05	ibutilide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD06	tedisamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD07	dronedarone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG	Other antiarrhythmics, class I and III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG01	moracizine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG07	cibenzoline	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG11	vernakalant	WHO Anatomical Therapeutic Chemical classification
0‑L	C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA	Adrenergic and dopaminergic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA01	etilefrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA02	isoprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA03	norepinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA04	dopamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA05	norfenefrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA06	phenylephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA07	dobutamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA08	oxedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA09	metaraminol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA10	methoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA11	mephentermine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA12	dimetofrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA13	prenalterol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA14	dopexamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA15	gepefrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA16	ibopamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA17	midodrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA18	octopamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA19	fenoldopam	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA21	cafedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA22	arbutamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA23	theodrenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA24	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA25	amezinium metilsulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA26	ephedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA27	droxidopa	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA51	etilefrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE	Phosphodiesterase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE01	amrinone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE02	milrinone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE03	enoximone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE04	bucladesine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX	Other cardiac stimulants	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX06	angiotensinamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX07	xamoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX08	levosimendan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX09	angiotensin II	WHO Anatomical Therapeutic Chemical classification
0‑L	C01D	VASODILATORS USED IN CARDIAC DISEASES	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA	Organic nitrates	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA02	glyceryl trinitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA04	methylpropylpropanediol dinitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA05	pentaerithrityl tetranitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA07	propatylnitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA08	isosorbide dinitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA09	trolnitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA13	eritrityl tetranitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA14	isosorbide mononitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA20	organic nitrates in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA38	tenitramine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA52	glyceryl trinitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA54	methylpropylpropanediol dinitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA55	pentaerithrityl tetranitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA57	propatylnitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA58	isosorbide dinitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA59	trolnitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA63	eritrityl tetranitrate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA70	organic nitrates in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DB	Quinolone vasodilators	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DB01	flosequinan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX	Other vasodilators used in cardiac diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX01	itramin tosilate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX02	prenylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX03	oxyfedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX04	benziodarone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX05	carbocromen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX06	hexobendine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX07	etafenone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX08	heptaminol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX09	imolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX10	dilazep	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX11	trapidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX12	molsidomine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX13	efloxate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX14	cinepazet	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX15	cloridarol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX16	nicorandil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX18	linsidomine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX19	nesiritide	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX21	serelaxin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX22	vericiguat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX51	itramin tosilate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX52	prenylamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX53	oxyfedrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX54	benziodarone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01E	OTHER CARDIAC PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EA	Prostaglandins	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EA01	alprostadil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB	Other cardiac preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB02	camphora	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB03	indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB04	crataegus glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB05	creatinolfosfate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB06	fosfocreatine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB07	fructose 1,6-diphosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB09	ubidecarenone	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB10	adenosine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB11	tiracizine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB13	acadesine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB15	trimetazidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB16	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB17	ivabradine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB18	ranolazine	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB21	regadenoson	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB22	meldonium	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB23	tiazotic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EX	Other cardiac combination products	WHO Anatomical Therapeutic Chemical classification
0‑L	C02	ANTIHYPERTENSIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	C02A	ANTIADRENERGIC AGENTS, CENTRALLY ACTING	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA	Rauwolfia alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA01	rescinnamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA02	reserpine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA03	combinations of rauwolfia alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA04	rauwolfia alkaloids, whole root	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA05	deserpidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA06	methoserpidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA07	bietaserpine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA52	reserpine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA53	combinations of rauwolfia alkoloids, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA57	bietaserpine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB	Methyldopa	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB01	methyldopa (levorotatory)	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB02	methyldopa (racemic)	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC	Imidazoline receptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC01	clonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC02	guanfacine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC04	tolonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC05	moxonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC06	rilmenidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02B	ANTIADRENERGIC AGENTS, GANGLION-BLOCKING	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BA	Sulfonium derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BA01	trimetaphan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BB	Secondary and tertiary amines	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BB01	mecamylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BC	Bisquaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	C02C	ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA	Alpha-adrenoreceptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA01	prazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA02	indoramin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA03	trimazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA04	doxazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA06	urapidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC	Guanidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC01	betanidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC02	guanethidine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC03	guanoxan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC04	debrisoquine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC05	guanoclor	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC06	guanazodine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC07	guanoxabenz	WHO Anatomical Therapeutic Chemical classification
0‑L	C02D	ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DA	Thiazide derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DA01	diazoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB	Hydrazinophthalazine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB01	dihydralazine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB02	hydralazine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB03	endralazine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB04	cadralazine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DC	Pyrimidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DC01	minoxidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DD	Nitroferricyanide derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DD01	nitroprusside	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DG	Guanidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DG01	pinacidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02K	OTHER ANTIHYPERTENSIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KA	Alkaloids, excl. rauwolfia	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KA01	veratrum	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KB	Tyrosine hydroxylase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KB01	metirosine	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KC	MAO inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KC01	pargyline	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KD	Serotonin antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KD01	ketanserin	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX	Antihypertensives for pulmonary arterial hypertension	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX01	bosentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX02	ambrisentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX03	sitaxentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX04	macitentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX05	riociguat	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX52	ambrisentan and tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02L	ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA	Rauwolfia alkaloids and diuretics in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA01	reserpine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA02	rescinnamine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA03	deserpidine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA04	methoserpidine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA07	bietaserpine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA08	rauwolfia alkaloids, whole root and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA09	syrosingopine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA50	combination of rauwolfia alkaloids and diuretics incl. other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA51	reserpine and diuretics, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA52	rescinnamine and diuretics, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA71	reserpine and diuretics, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LB	Methyldopa and diuretics in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LB01	methyldopa (levorotatory) and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC	Imidazoline receptor agonists in combination with diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC01	clonidine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC05	moxonidine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC51	clonidine and diuretics, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LE	Alpha-adrenoreceptor antagonists and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LE01	prazosin and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LF	Guanidine derivatives and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LF01	guanethidine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG	Hydrazinophthalazine derivatives and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG01	dihydralazine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG02	hydralazine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG03	picodralazine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG51	dihydralazine and diuretics, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG73	picodralazine and diuretics, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LK	Alkaloids, excl. rauwolfia, in combination with diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LK01	veratrum and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LL	MAO inhibitors and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LL01	pargyline and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LN	Serotonin antagonists and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LX	Other antihypertensives and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LX01	pinacidil and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C02N	COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02	WHO Anatomical Therapeutic Chemical classification
0‑L	C03	DIURETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	C03A	LOW-CEILING DIURETICS, THIAZIDES	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA	Thiazides, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA01	bendroflumethiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA02	hydroflumethiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA03	hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA04	chlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA05	polythiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA06	trichlormethiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA07	cyclopenthiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA08	methyclothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA09	cyclothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA13	mebutizide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB	Thiazides and potassium in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB01	bendroflumethiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB02	hydroflumethiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB03	hydrochlorothiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB04	chlorothiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB05	polythiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB06	trichlormethiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB07	cyclopenthiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB08	methyclothiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB09	cyclothiazide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH	Thiazides, combinations with psycholeptics and/or analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH01	chlorothiazide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH02	hydroflumethiazide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AX	Thiazides, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AX01	hydrochlorothiazide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C03B	LOW-CEILING DIURETICS, EXCL. THIAZIDES	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA	Sulfonamides, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA02	quinethazone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA03	clopamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA04	chlortalidone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA05	mefruside	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA07	clofenamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA08	metolazone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA09	meticrane	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA10	xipamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA11	indapamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA12	clorexolone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA13	fenquizone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA82	clorexolone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB	Sulfonamides and potassium in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB02	quinethazone and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB03	clopamide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB04	chlortalidone and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB05	mefruside and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB07	clofenamide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BC	Mercurial diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BC01	mersalyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BD	Xanthine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BD01	theobromine	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BK	Sulfonamides, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BX	Other low-ceiling diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BX03	cicletanine	WHO Anatomical Therapeutic Chemical classification
0‑L	C03C	HIGH-CEILING DIURETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA	Sulfonamides, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA01	furosemide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA02	bumetanide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA03	piretanide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA04	torasemide	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB	Sulfonamides and potassium in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB01	furosemide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB02	bumetanide and potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC	Aryloxyacetic acid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC01	etacrynic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC02	tienilic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CD	Pyrazolone derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CD01	muzolimine	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CX	Other high-ceiling diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CX01	etozolin	WHO Anatomical Therapeutic Chemical classification
0‑L	C03D	POTASSIUM-SPARING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA	Aldosterone antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA01	spironolactone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA02	potassium canrenoate	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA03	canrenone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA04	eplerenone	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB	Other potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB01	amiloride	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB02	triamterene	WHO Anatomical Therapeutic Chemical classification
0‑L	C03E	DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA	Low-ceiling diuretics and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA01	hydrochlorothiazide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA02	trichlormethiazide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA03	epitizide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA04	altizide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA05	mebutizide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA06	chlortalidone and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA07	cyclopenthiazide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA12	metolazone and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA13	bendroflumethiazide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA14	butizide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB	High-ceiling diuretics and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB01	furosemide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB02	bumetanide and potassium-sparing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C03X	OTHER DIURETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	C03XA	Vasopressin antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	C03XA01	tolvaptan	WHO Anatomical Therapeutic Chemical classification
0‑L	C03XA02	conivaptan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04	PERIPHERAL VASODILATORS	WHO Anatomical Therapeutic Chemical classification
0‑L	C04A	PERIPHERAL VASODILATORS	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA	2-amino-1-phenylethanol derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA01	isoxsuprine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA02	buphenine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA31	bamethan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB	Imidazoline derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB01	phentolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB02	tolazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC	Nicotinic acid and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC01	nicotinic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC02	nicotinyl alcohol (pyridylcarbinol)	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC03	inositol nicotinate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC07	ciclonicate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD	Purine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD01	pentifylline	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD02	xantinol nicotinate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD03	pentoxifylline	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD04	etofylline nicotinate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE	Ergot alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE01	ergoloid mesylates	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE02	nicergoline	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE04	dihydroergocristine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE51	ergoloid mesylates, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE54	dihydroergocristine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AF	Enzymes	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AF01	kallidinogenase	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX	Other peripheral vasodilators	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX01	cyclandelate	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX02	phenoxybenzamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX07	vincamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX10	moxisylyte	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX11	bencyclane	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX17	vinburnine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX19	suloctidil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX20	buflomedil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX21	naftidrofuryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX23	butalamine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX24	visnadine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX26	cetiedil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX27	cinepazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX28	ifenprodil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX30	azapetine	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX32	fasudil	WHO Anatomical Therapeutic Chemical classification
0‑L	C05	VASOPROTECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	C05A	AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA	Corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA01	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA04	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA05	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA06	fluorometholone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA08	fluocortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA09	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA10	fluocinolone acetonide	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA11	fluocinonide	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA12	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AB	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD	Local anesthetics	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD01	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD02	tetracaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD03	benzocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD04	cinchocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD05	procaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD06	oxetacaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD07	pramocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE	Muscle relaxants	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE01	glyceryl trinitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE02	isosorbide dinitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE03	diltiazem	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX	Other agents for treatment of hemorrhoids and anal fissures for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX01	aluminium preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX02	bismuth preparations, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX03	other preparations, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX04	zinc preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX05	tribenoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C05B	ANTIVARICOSE THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA	Heparins or heparinoids for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA01	organo-heparinoid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA02	sodium apolate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA03	heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA04	pentosan polysulfate sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA51	heparinoid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA53	heparin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB	Sclerosing agents for local injection	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB01	monoethanolamine oleate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB02	polidocanol	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB03	invert sugar	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB04	sodium tetradecyl sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB05	phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB56	glucose, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX	Other sclerosing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX01	calcium dobesilate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX51	calcium dobesilate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05C	CAPILLARY STABILIZING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA	Bioflavonoids	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA01	rutoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA02	monoxerutin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA03	diosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA04	troxerutin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA05	hidrosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA51	rutoside, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA53	diosmin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA54	troxerutin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX	Other capillary stabilizing agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX01	tribenoside	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX02	naftazone	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX03	Hippocastani semen	WHO Anatomical Therapeutic Chemical classification
0‑L	C07	BETA BLOCKING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C07A	BETA BLOCKING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA	Beta blocking agents, non-selective	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA01	alprenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA02	oxprenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA03	pindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA05	propranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA06	timolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA07	sotalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA12	nadolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA14	mepindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA15	carteolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA16	tertatolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA17	bopindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA19	bupranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA23	penbutolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA27	cloranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB	Beta blocking agents, selective	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB01	practolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB02	metoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB03	atenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB04	acebutolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB05	betaxolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB06	bevantolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB07	bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB08	celiprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB09	esmolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB10	epanolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB11	s-atenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB12	nebivolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB13	talinolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB14	landiolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG	Alpha and beta blocking agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG01	labetalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG02	carvedilol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07B	BETA BLOCKING AGENTS AND THIAZIDES	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA	Beta blocking agents, non-selective, and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA02	oxprenolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA05	propranolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA06	timolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA07	sotalol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA12	nadolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA68	metipranolol and thiazides, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB	Beta blocking agents, selective, and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB02	metoprolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB03	atenolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB04	acebutolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB06	bevantolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB07	bisoprolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB12	nebivolol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB52	metoprolol and thiazides, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BG	Alpha and beta blocking agents and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BG01	labetalol and thiazides	WHO Anatomical Therapeutic Chemical classification
0‑L	C07C	BETA BLOCKING AGENTS AND OTHER DIURETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA	Beta blocking agents, non-selective, and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA02	oxprenolol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA03	pindolol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA17	bopindolol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA23	penbutolol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB	Beta blocking agents, selective, and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB02	metoprolol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB03	atenolol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB53	atenolol and other diuretics, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CG	Alpha and beta blocking agents and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CG01	labetalol and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07D	BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DA	Beta blocking agents, non-selective, thiazides and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DA06	timolol, thiazides and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DB	Beta blocking agents, selective, thiazides and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DB01	atenolol, thiazides and other diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C07E	BETA BLOCKING AGENTS AND VASODILATORS	WHO Anatomical Therapeutic Chemical classification
0‑L	C07EA	Beta blocking agents, non-selective, and vasodilators	WHO Anatomical Therapeutic Chemical classification
0‑L	C07EB	Beta blocking agents, selective, and vasodilators	WHO Anatomical Therapeutic Chemical classification
0‑L	C07F	BETA BLOCKING AGENTS, OTHER COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB	Beta blocking agents and calcium channel blockers	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB02	metoprolol and felodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB03	atenolol and nifedipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB07	bisoprolol and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB12	nebivolol and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB13	metoprolol and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX	Beta blocking agents, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX01	propranolol and other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX02	sotalol and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX03	metoprolol and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX04	bisoprolol and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX05	metoprolol and ivabradine	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX06	carvedilol and ivabradine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08	CALCIUM CHANNEL BLOCKERS	WHO Anatomical Therapeutic Chemical classification
0‑L	C08C	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA	Dihydropyridine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA01	amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA02	felodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA03	isradipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA04	nicardipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA05	nifedipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA06	nimodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA07	nisoldipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA08	nitrendipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA09	lacidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA10	nilvadipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA11	manidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA12	barnidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA13	lercanidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA14	cilnidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA15	benidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA16	clevidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA51	amlodipine and celecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA55	nifedipine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CX	Other selective calcium channel blockers with mainly vascular effects	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CX01	mibefradil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08D	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA	Phenylalkylamine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA01	verapamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA02	gallopamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA51	verapamil, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DB	Benzothiazepine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DB01	diltiazem	WHO Anatomical Therapeutic Chemical classification
0‑L	C08E	NON-SELECTIVE CALCIUM CHANNEL BLOCKERS	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA	Phenylalkylamine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA01	fendiline	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA02	bepridil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX	Other non-selective calcium channel blockers	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX01	lidoflazine	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX02	perhexiline	WHO Anatomical Therapeutic Chemical classification
0‑L	C08G	CALCIUM CHANNEL BLOCKERS AND DIURETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA	Calcium channel blockers and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA01	nifedipine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA02	amlodipine and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	C09A	ACE INHIBITORS, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA	ACE inhibitors, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA01	captopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA02	enalapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA03	lisinopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA04	perindopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA05	ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA06	quinapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA07	benazepril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA08	cilazapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA09	fosinopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA10	trandolapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA11	spirapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA12	delapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA13	moexipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA14	temocapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA15	zofenopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA16	imidapril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09B	ACE INHIBITORS, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA	ACE inhibitors and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA01	captopril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA02	enalapril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA03	lisinopril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA04	perindopril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA05	ramipril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA06	quinapril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA07	benazepril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA08	cilazapril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA09	fosinopril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA12	delapril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA13	moexipril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA15	zofenopril and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB	ACE inhibitors and calcium channel blockers	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB02	enalapril and lercanidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB03	lisinopril and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB04	perindopril and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB05	ramipril and felodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB06	enalapril and nitrendipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB07	ramipril and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB10	trandolapril and verapamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB12	delapril and manidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX	ACE inhibitors, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX01	perindopril, amlodipine and indapamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX02	perindopril and bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX03	ramipril, amlodipine and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX04	perindopril, bisoprolol and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX05	ramipril and bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09C	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA	Angiotensin II receptor blockers (ARBs), plain	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA01	losartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA02	eprosartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA03	valsartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA04	irbesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA05	tasosartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA06	candesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA07	telmisartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA08	olmesartan medoxomil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA09	azilsartan medoxomil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA10	fimasartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09D	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA	Angiotensin II receptor blockers (ARBs) and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA01	losartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA02	eprosartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA03	valsartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA04	irbesartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA06	candesartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA07	telmisartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA08	olmesartan medoxomil and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA09	azilsartan medoxomil and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA10	fimasartan and diuretics	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB	Angiotensin II receptor blockers (ARBs) and calcium channel blockers	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB01	valsartan and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB02	olmesartan medoxomil and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB04	telmisartan and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB05	irbesartan and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB06	losartan and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB07	candesartan and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB08	valsartan and lercanidipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB09	fimasartan and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX	Angiotensin II receptor blockers (ARBs), other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX01	valsartan, amlodipine and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX02	valsartan and aliskiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX03	olmesartan medoxomil, amlodipine and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX04	valsartan and sacubitril	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX05	valsartan and nebivolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX06	candesartan, amlodipine and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX07	irbesartan, amlodipine and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09X	OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA	Renin-inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA01	remikiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA02	aliskiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA52	aliskiren and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA53	aliskiren and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA54	aliskiren, amlodipine and hydrochlorothiazide	WHO Anatomical Therapeutic Chemical classification
0‑L	C10	LIPID MODIFYING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	C10A	LIPID MODIFYING AGENTS, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA	HMG CoA reductase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA01	simvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA02	lovastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA03	pravastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA04	fluvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA05	atorvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA06	cerivastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA07	rosuvastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA08	pitavastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB	Fibrates	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB01	clofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB02	bezafibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB03	aluminium clofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB04	gemfibrozil	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB05	fenofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB06	simfibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB07	ronifibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB08	ciprofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB09	etofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB10	clofibride	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB11	choline fenofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC	Bile acid sequestrants	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC01	colestyramine	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC02	colestipol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC03	colextran	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC04	colesevelam	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD	Nicotinic acid and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD01	niceritrol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD02	nicotinic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD03	nicofuranose	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD04	aluminium nicotinate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD05	nicotinyl alcohol (pyridylcarbinol)	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD06	acipimox	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD52	nicotinic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX	Other lipid modifying agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX01	dextrothyroxine	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX02	probucol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX03	tiadenol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX05	meglutol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX06	omega-3-triglycerides incl. other esters and acids	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX07	magnesium pyridoxal 5-phosphate glutamate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX08	policosanol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX09	ezetimibe	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX10	alipogene tiparvovec	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX11	mipomersen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX12	lomitapide	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX13	evolocumab	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX14	alirocumab	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX15	bempedoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX16	inclisiran	WHO Anatomical Therapeutic Chemical classification
0‑L	C10B	LIPID MODIFYING AGENTS, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA	Combinations of various lipid modifying agents	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA01	lovastatin and nicotinic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA02	simvastatin and ezetimibe	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA03	pravastatin and fenofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA04	simvastatin and fenofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA05	atorvastatin and ezetimibe	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA06	rosuvastatin and ezetimibe	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA07	rosuvastatin and omega-3 fatty acids	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA08	atorvastatin and omega-3 fatty acids	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA09	rosuvastatin and fenofibrate	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA10	bempedoic acid and ezetimibe	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX	Lipid modifying agents in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX01	simvastatin and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX02	pravastatin and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX03	atorvastatin and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX04	simvastatin, acetylsalicylic acid and ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX05	rosuvastatin and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX06	atorvastatin, acetylsalicylic acid and ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX07	rosuvastatin, amlodipine and lisinopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX08	atorvastatin and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX09	rosuvastatin and amlodipine	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX10	rosuvastatin and valsartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX11	atorvastatin, amlodipine and perindopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX12	atorvastatin, acetylsalicylic acid and perindopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX13	rosuvastatin, perindopril and indapamide	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX14	rosuvastatin, amlodipine and perindopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX15	atorvastatin and perindopril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX16	rosuvastatin and fimasartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX17	rosuvastatin and ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX18	atorvastatin, amlodipine and ramipril	WHO Anatomical Therapeutic Chemical classification
0‑L	D	DERMATOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	D01	ANTIFUNGALS FOR DERMATOLOGICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D01A	ANTIFUNGALS FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA01	nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA02	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA03	hachimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA04	pecilocin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA06	mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA07	pyrrolnitrin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA08	griseofulvin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC	Imidazole and triazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC01	clotrimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC02	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC03	econazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC04	chlormidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC05	isoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC06	tiabendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC07	tioconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC08	ketoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC09	sulconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC10	bifonazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC11	oxiconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC12	fenticonazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC13	omoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC14	sertaconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC15	fluconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC16	flutrimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC17	eberconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC18	luliconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC19	efinaconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC20	imidazoles/triazoles in combination with corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC52	miconazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC60	bifonazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE	Other antifungals for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE01	bromochlorosalicylanilide	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE02	methylrosaniline	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE03	tribromometacresol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE04	undecylenic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE05	polynoxylin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE06	2-(4-chlorphenoxy)-ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE07	chlorphenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE08	ticlatone	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE09	sulbentine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE10	ethyl hydroxybenzoate	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE11	haloprogin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE12	salicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE13	selenium sulfide	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE14	ciclopirox	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE15	terbinafine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE16	amorolfine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE17	dimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE18	tolnaftate	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE19	tolciclate	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE21	flucytosine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE22	naftifine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE23	butenafine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE24	tavaborole	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE54	undecylenic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D01B	ANTIFUNGALS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA	Antifungals for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA01	griseofulvin	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA02	terbinafine	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA03	fosravuconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D02	EMOLLIENTS AND PROTECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	D02A	EMOLLIENTS AND PROTECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AA	Silicone products	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AB	Zinc products	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AC	Soft paraffin and fat products	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AD	Liquid plasters	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE	Carbamide products	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE01	carbamide	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE51	carbamide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AF	Salicylic acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AX	Other emollients and protectives	WHO Anatomical Therapeutic Chemical classification
0‑L	D02B	PROTECTIVES AGAINST UV-RADIATION	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA	Protectives against UV-radiation for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA01	aminobenzoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA02	octinoxate	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB	Protectives against UV-radiation for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB01	betacarotene	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB02	afamelanotide	WHO Anatomical Therapeutic Chemical classification
0‑L	D03	PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS	WHO Anatomical Therapeutic Chemical classification
0‑L	D03A	CICATRIZANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AA	Cod-liver oil ointments	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX	Other cicatrizants	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX01	cadexomer iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX02	dextranomer	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX03	dexpanthenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX04	calcium pantothenate	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX05	hyaluronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX06	becaplermin	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX09	crilanomer	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX10	enoxolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX11	sodium chlorite	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX12	trolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX13	Betulae cortex	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX14	Centella asiatica herba	WHO Anatomical Therapeutic Chemical classification
0‑L	D03B	ENZYMES	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA	Proteolytic enzymes	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA01	trypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA02	collagenase	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA03	bromelains	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA52	collagenase, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D04	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.	WHO Anatomical Therapeutic Chemical classification
0‑L	D04A	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA	Antihistamines for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA01	thonzylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA02	mepyramine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA03	thenalidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA04	tripelennamine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA09	chloropyramine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA10	promethazine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA12	tolpropamine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA13	dimetindene	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA14	clemastine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA15	bamipine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA16	pheniramine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA22	isothipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA32	diphenhydramine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA33	diphenhydramine methylbromide	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA34	chlorphenoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB	Anesthetics for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB01	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB02	cinchocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB03	oxybuprocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB04	benzocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB05	quinisocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB06	tetracaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB07	pramocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AX	Other antipruritics	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AX01	doxepin	WHO Anatomical Therapeutic Chemical classification
0‑L	D05	ANTIPSORIATICS	WHO Anatomical Therapeutic Chemical classification
0‑L	D05A	ANTIPSORIATICS FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AA	Tars	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC	Antracen derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC01	dithranol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC51	dithranol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD	Psoralens for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD01	trioxysalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD02	methoxsalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX	Other antipsoriatics for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX01	fumaric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX02	calcipotriol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX03	calcitriol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX04	tacalcitol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX05	tazarotene	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX52	calcipotriol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX55	tazarotene and ulobetasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05B	ANTIPSORIATICS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA	Psoralens for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA01	trioxysalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA02	methoxsalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA03	bergapten	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB	Retinoids for treatment of psoriasis	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB01	etretinate	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB02	acitretin	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BX	Other antipsoriatics for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BX51	fumaric acid derivatives, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D06A	ANTIBIOTICS FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA	Tetracycline and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA01	demeclocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA02	chlortetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA03	oxytetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA04	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX	Other antibiotics for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX01	fusidic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX02	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX04	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX05	bacitracin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX07	gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX08	tyrothricin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX09	mupirocin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX10	virginiamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX11	rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX12	amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX13	retapamulin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX14	ozenoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX15	rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06B	CHEMOTHERAPEUTICS FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA	Sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA01	silver sulfadiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA02	sulfathiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA03	mafenide	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA04	sulfamethizole	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA05	sulfanilamide	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA06	sulfamerazine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA51	silver sulfadiazine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB	Antivirals	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB01	idoxuridine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB02	tromantadine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB03	aciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB04	podophyllotoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB05	inosine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB06	penciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB07	lysozyme	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB08	ibacitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB09	edoxudine	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB10	imiquimod	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB11	docosanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB12	sinecatechins	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB53	aciclovir, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX	Other chemotherapeutics	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX01	metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX02	ingenol mebutate	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX03	tirbanibulin	WHO Anatomical Therapeutic Chemical classification
0‑L	D06C	ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	D07A	CORTICOSTEROIDS, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA	Corticosteroids, weak (group I)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA01	methylprednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA02	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA03	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB	Corticosteroids, moderately potent (group II)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB01	clobetasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB02	hydrocortisone butyrate	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB03	flumetasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB04	fluocortin	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB05	fluperolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB06	fluorometholone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB07	fluprednidene	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB08	desonide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB09	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB10	alclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB11	hydrocortisone buteprate	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB19	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB21	clocortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB30	combinations of corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC	Corticosteroids, potent (group III)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC01	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC02	fluclorolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC03	desoximetasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC04	fluocinolone acetonide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC05	fluocortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC06	diflucortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC07	fludroxycortide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC08	fluocinonide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC09	budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC10	diflorasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC11	amcinonide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC12	halometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC13	mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC14	methylprednisolone aceponate	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC15	beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC16	hydrocortisone aceponate	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC17	fluticasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC18	prednicarbate	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC19	difluprednate	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC21	ulobetasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD	Corticosteroids, very potent (group IV)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD01	clobetasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD02	halcinonide	WHO Anatomical Therapeutic Chemical classification
0‑L	D07B	CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA	Corticosteroids, weak, combinations with antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA01	prednisolone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA04	hydrocortisone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB	Corticosteroids, moderately potent, combinations with antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB01	flumetasone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB02	desonide and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB03	triamcinolone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB04	hydrocortisone butyrate and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC	Corticosteroids, potent, combinations with antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC01	betamethasone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC02	fluocinolone acetonide and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC03	fluocortolone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC04	diflucortolone and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BD	Corticosteroids, very potent, combinations with antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07C	CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA	Corticosteroids, weak, combinations with antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA01	hydrocortisone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA02	methylprednisolone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA03	prednisolone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB	Corticosteroids, moderately potent, combinations with antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB01	triamcinolone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB02	fluprednidene and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB03	fluorometholone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB04	dexamethasone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB05	flumetasone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC	Corticosteroids, potent, combinations with antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC01	betamethasone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC02	fluocinolone acetonide and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC03	fludroxycortide and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC04	beclometasone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC05	fluocinonide and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC06	fluocortolone and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CD	Corticosteroids, very potent, combinations with antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CD01	clobetasol and antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D07X	CORTICOSTEROIDS, OTHER COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA	Corticosteroids, weak, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA01	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA02	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB	Corticosteroids, moderately potent, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB01	flumetasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB02	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB03	fluprednidene	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB04	fluorometholone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB05	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB30	combinations of corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC	Corticosteroids, potent, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC01	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC02	desoximetasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC03	mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC04	diflucortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC05	fluocortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XD	Corticosteroids, very potent, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D08	ANTISEPTICS AND DISINFECTANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	D08A	ANTISEPTICS AND DISINFECTANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA	Acridine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA01	ethacridine lactate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA02	aminoacridine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA03	euflavine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AB	Aluminium agents	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC	Biguanides and amidines	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC01	dibrompropamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC02	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC03	propamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC04	hexamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC05	polihexanide	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC52	chlorhexidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AD	Boric acid products	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE	Phenol and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE01	hexachlorophene	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE02	policresulen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE03	phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE04	triclosan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE05	chloroxylenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE06	biphenylol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AF	Nitrofuran derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AF01	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG	Iodine products	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG01	iodine/octylphenoxypolyglycolether	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG02	povidone-iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG03	iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG04	diiodohydroxypropane	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH	Quinoline derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH01	dequalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH02	chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH03	oxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH30	clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ	Quaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ01	benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ02	cetrimonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ03	cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ04	cetrimide	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ05	benzoxonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ06	didecyldimethylammonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ08	benzethonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ10	decamethoxine	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ57	octenidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ58	benzethonium chloride, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ59	dodeclonium bromide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK	Mercurial products	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK01	mercuric amidochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK02	phenylmercuric borate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK03	mercuric chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK04	merbromin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK05	mercury, metallic	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK06	thiomersal	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK30	mercuric iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL	Silver compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL01	silver nitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL30	silver	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX	Other antiseptics and disinfectants	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX01	hydrogen peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX02	eosin	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX03	propanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX04	tosylchloramide sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX05	isopropanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX06	potassium permanganate	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX07	sodium hypochlorite	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX08	ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX53	propanol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D09	MEDICATED DRESSINGS	WHO Anatomical Therapeutic Chemical classification
0‑L	D09A	MEDICATED DRESSINGS	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA	Medicated dressings with antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA01	framycetin	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA02	fusidic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA03	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA04	phenylmercuric nitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA05	benzododecinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA06	triclosan	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA07	cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA08	aluminium chlorohydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA09	povidone-iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA10	clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA11	benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA12	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA13	iodoform	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB	Zinc bandages	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB01	zinc bandage without supplements	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB02	zinc bandage with supplements	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AX	Soft paraffin dressings	WHO Anatomical Therapeutic Chemical classification
0‑L	D10	ANTI-ACNE PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	D10A	ANTI-ACNE PREPARATIONS FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA	Corticosteroids, combinations for treatment of acne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA01	fluorometholone	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA02	methylprednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA03	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB	Preparations containing sulfur	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB01	bithionol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB02	sulfur	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB03	tioxolone	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB05	mesulfen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD	Retinoids for topical use in acne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD01	tretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD02	retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD03	adapalene	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD04	isotretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD05	motretinide	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD06	trifarotene	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD51	tretinoin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD53	adapalene, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD54	isotretinoin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE	Peroxides	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE01	benzoyl peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE51	benzoyl peroxide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF	Antiinfectives for treatment of acne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF01	clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF02	erythromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF03	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF04	meclocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF05	nadifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF06	sulfacetamide	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF07	minocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF51	clindamycin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF52	erythromycin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX	Other anti-acne preparations for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX01	aluminium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX02	resorcinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX03	azelaic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX04	aluminium oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX05	dapsone	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX30	various combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D10B	ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BA	Retinoids for treatment of acne	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BA01	isotretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BX	Other anti-acne preparations for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BX01	ichtasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11	OTHER DERMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	D11A	OTHER DERMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AA	Antihidrotics	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AA01	glycopyrronium	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC	Medicated shampoos	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC01	cetrimide	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC02	cadmium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC03	selenium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC06	povidone-iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC08	sulfur compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC09	xenysalate	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC30	others	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AE	Androgens for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AE01	metandienone	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AF	Wart and anti-corn preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH	Agents for dermatitis, excluding corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH01	tacrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH02	pimecrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH03	cromoglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH04	alitretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH05	dupilumab	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH06	crisaborole	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH07	tralokinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX	Other dermatologicals	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX01	minoxidil	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX02	gamolenic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX03	calcium gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX04	lithium succinate	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX05	magnesium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX06	mequinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX08	tiratricol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX09	oxaceprol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX10	finasteride	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX11	hydroquinone	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX12	pyrithione zinc	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX13	monobenzone	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX16	eflornithine	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX18	diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX21	brimonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX22	ivermectin	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX23	aminobenzoate potassium	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX24	deoxycholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX25	hydrogen peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX26	caffeine	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX52	gamolenic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX57	collagen, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G	GENITO URINARY SYSTEM AND SEX HORMONES	WHO Anatomical Therapeutic Chemical classification
0‑L	G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA01	nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA02	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA03	amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA04	candicidin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA05	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA06	hachimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA07	oxytetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA08	carfecillin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA09	mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA10	clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA11	pentamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA51	nystatin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AB	Arsenic compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AB01	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC	Quinoline derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC01	diiodohydroxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC02	clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC03	chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC05	dequalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC06	broxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC30	oxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD	Organic acids	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD01	lactic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD02	acetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD03	ascorbic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE	Sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE01	sulfatolamide	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE10	combinations of sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF	Imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF01	metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF02	clotrimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF04	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF05	econazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF06	ornidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF07	isoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF08	tioconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF11	ketoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF12	fenticonazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF13	azanidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF14	propenidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF15	butoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF16	omoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF17	oxiconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF18	flutrimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF19	sertaconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF20	combinations of imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF55	econazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AG	Triazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AG02	terconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX	Other antiinfectives and antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX01	clodantoin	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX02	inosine	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX03	policresulen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX05	nifuratel	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX06	furazolidone	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX09	methylrosaniline	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX11	povidone-iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX12	ciclopirox	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX13	protiofate	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX14	lactobacillus	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX15	copper usnate	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX16	hexetidine	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX17	dapivirine	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX66	octenidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G01B	ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BA	Antibiotics and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BC	Quinoline derivatives and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BD	Antiseptics and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BE	Sulfonamides and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BF	Imidazole derivatives and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	G02	OTHER GYNECOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	G02A	UTEROTONICS	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB	Ergot alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB01	methylergometrine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB02	ergot alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB03	ergometrine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AC	Ergot alkaloids and oxytocin incl. analogues, in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AC01	methylergometrine and oxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD	Prostaglandins	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD01	dinoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD02	dinoprostone	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD03	gemeprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD04	carboprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD05	sulprostone	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD06	misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AX	Other uterotonics	WHO Anatomical Therapeutic Chemical classification
0‑L	G02B	CONTRACEPTIVES FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA	Intrauterine contraceptives	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA01	plastic IUD	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA02	plastic IUD with copper	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA03	plastic IUD with progestogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB	Intravaginal contraceptives	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB01	vaginal ring with progestogen and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB02	vaginal ring with progestogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02C	OTHER GYNECOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA	Sympathomimetics, labour repressants	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA01	ritodrine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA02	buphenine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA03	fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB	Prolactine inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB01	bromocriptine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB02	lisuride	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB03	cabergoline	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB04	quinagolide	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB05	metergoline	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB06	terguride	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC	Antiinflammatory products for vaginal administration	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC01	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC02	naproxen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC03	benzydamine	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC04	flunoxaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX	Other gynecologicals	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX01	atosiban	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX02	flibanserin	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX03	Agni casti fructus	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX04	Cimicifugae rhizoma	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX05	bremelanotide	WHO Anatomical Therapeutic Chemical classification
0‑L	G03	SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	G03A	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA	Progestogens and estrogens, fixed combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA01	etynodiol and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA02	quingestanol and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA03	lynestrenol and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA04	megestrol and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA05	norethisterone and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA06	norgestrel and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA07	levonorgestrel and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA08	medroxyprogesterone and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA09	desogestrel and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA10	gestodene and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA11	norgestimate and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA12	drospirenone and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA13	norelgestromin and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA14	nomegestrol and estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA15	chlormadinone and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA16	dienogest and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA17	medroxyprogesterone and estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA18	drospirenone and estetrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB	Progestogens and estrogens, sequential preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB01	megestrol and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB02	lynestrenol and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB03	levonorgestrel and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB04	norethisterone and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB05	desogestrel and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB06	gestodene and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB07	chlormadinone and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB08	dienogest and estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB09	norgestimate and ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC	Progestogens	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC01	norethisterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC02	lynestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC03	levonorgestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC04	quingestanol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC05	megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC06	medroxyprogesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC07	norgestrienone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC08	etonogestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC09	desogestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC10	drospirenone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD	Emergency contraceptives	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD01	levonorgestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD02	ulipristal	WHO Anatomical Therapeutic Chemical classification
0‑L	G03B	ANDROGENS	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA	3-oxoandrosten (4) derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA01	fluoxymesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA02	methyltestosterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA03	testosterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB	5-androstanon (3) derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB01	mesterolone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB02	androstanolone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03C	ESTROGENS	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA	Natural and semisynthetic estrogens, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA01	ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA03	estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA04	estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA06	chlorotrianisene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA07	estrone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA09	promestriene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA53	estradiol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA57	conjugated estrogens	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB	Synthetic estrogens, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB01	dienestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB02	diethylstilbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB03	methallenestril	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB04	moxestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC	Estrogens, combinations with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC02	dienestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC03	methallenestril	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC04	estrone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC05	diethylstilbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC06	estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC07	conjugated estrogens and bazedoxifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CX	Other estrogens	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CX01	tibolone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03D	PROGESTOGENS	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA	Pregnen (4) derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA01	gestonorone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA02	medroxyprogesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA03	hydroxyprogesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA04	progesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB	Pregnadien derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB01	dydrogesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB02	megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB03	medrogestone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB04	nomegestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB05	demegestone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB06	chlormadinone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB07	promegestone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB08	dienogest	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC	Estren derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC01	allylestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC02	norethisterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC03	lynestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC04	ethisterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC06	etynodiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC31	methylestrenolone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03E	ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA	Androgens and estrogens	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA01	methyltestosterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA02	testosterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA03	prasterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EB	Androgen, progestogen and estrogen in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EK	Androgens and female sex hormones in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EK01	methyltestosterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03F	PROGESTOGENS AND ESTROGENS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA	Progestogens and estrogens, fixed combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA01	norethisterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA02	hydroxyprogesterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA03	ethisterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA04	progesterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA05	methylnortestosterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA06	etynodiol and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA07	lynestrenol and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA08	megestrol and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA09	noretynodrel and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA10	norgestrel and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA11	levonorgestrel and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA12	medroxyprogesterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA13	norgestimate and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA14	dydrogesterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA15	dienogest and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA16	trimegestone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA17	drospirenone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB	Progestogens and estrogens, sequential preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB01	norgestrel and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB02	lynestrenol and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB03	chlormadinone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB04	megestrol and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB05	norethisterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB06	medroxyprogesterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB07	medrogestone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB08	dydrogesterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB09	levonorgestrel and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB10	desogestrel and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB11	trimegestone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB12	nomegestrol and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03G	GONADOTROPINS AND OTHER OVULATION STIMULANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA	Gonadotropins	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA01	chorionic gonadotrophin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA02	human menopausal gonadotrophin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA03	serum gonadotrophin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA04	urofollitropin	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA05	follitropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA06	follitropin beta	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA07	lutropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA08	choriogonadotropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA09	corifollitropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA10	follitropin delta	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB	Ovulation stimulants, synthetic	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB01	cyclofenil	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB02	clomifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB03	epimestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03H	ANTIANDROGENS	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HA	Antiandrogens, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HA01	cyproterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HB	Antiandrogens and estrogens	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HB01	cyproterone and estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03X	OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA	Antigonadotropins and similar agents	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA01	danazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA02	gestrinone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB	Progesterone receptor modulators	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB01	mifepristone	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB02	ulipristal	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB51	mifepristone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC	Selective estrogen receptor modulators	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC01	raloxifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC02	bazedoxifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC03	lasofoxifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC04	ormeloxifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC05	ospemifene	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XX	Other sex hormones and modulators of the genital system	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XX01	prasterone	WHO Anatomical Therapeutic Chemical classification
0‑L	G04	UROLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	G04B	UROLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA	Acidifiers	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA01	ammonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA03	calcium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BC	Urinary concrement solvents	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD	Drugs for urinary frequency and incontinence	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD01	emepronium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD02	flavoxate	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD03	meladrazine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD04	oxybutynin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD05	terodiline	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD06	propiverine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD07	tolterodine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD08	solifenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD09	trospium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD10	darifenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD11	fesoterodine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD12	mirabegron	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD13	desfesoterodine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE	Drugs used in erectile dysfunction	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE01	alprostadil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE02	papaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE03	sildenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE04	yohimbine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE06	moxisylyte	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE07	apomorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE08	tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE09	vardenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE10	avanafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE11	udenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE52	papaverine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX	Other urologicals	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX01	magnesium hydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX03	acetohydroxamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX06	phenazopyridine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX10	succinimide	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX11	collagen	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX12	phenyl salicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX13	dimethyl sulfoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX14	dapoxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX15	pentosan polysulfate sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX16	tiopronin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04C	DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA	Alpha-adrenoreceptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA01	alfuzosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA02	tamsulosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA03	terazosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA04	silodosin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA51	alfuzosin and finasteride	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA52	tamsulosin and dutasteride	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA53	tamsulosin and solifenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA54	tamsulosin and tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB	Testosterone-5-alpha reductase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB01	finasteride	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB02	dutasteride	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX	Other drugs used in benign prostatic hypertrophy	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX01	Prunus africanae cortex	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX02	Sabalis serrulatae fructus	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX03	mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX04	fexapotide	WHO Anatomical Therapeutic Chemical classification
0‑L	H	SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS	WHO Anatomical Therapeutic Chemical classification
0‑L	H01	PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES	WHO Anatomical Therapeutic Chemical classification
0‑L	H01A	ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA	ACTH	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA01	corticotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA02	tetracosactide	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AB	Thyrotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AB01	thyrotropin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC	Somatropin and somatropin agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC01	somatropin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC02	somatrem	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC03	mecasermin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC04	sermorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC05	mecasermin rinfabate	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC06	tesamorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC07	somapacitan	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AX	Other anterior pituitary lobe hormones and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AX01	pegvisomant	WHO Anatomical Therapeutic Chemical classification
0‑L	H01B	POSTERIOR PITUITARY LOBE HORMONES	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA	Vasopressin and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA01	vasopressin (argipressin)	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA02	desmopressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA03	lypressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA04	terlipressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA05	ornipressin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB	Oxytocin and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB01	demoxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB02	oxytocin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB03	carbetocin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01C	HYPOTHALAMIC HORMONES	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA	Gonadotropin-releasing hormones	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA01	gonadorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA02	nafarelin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB	Somatostatin and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB01	somatostatin	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB02	octreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB03	lanreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB04	vapreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB05	pasireotide	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC	Anti-gonadotropin-releasing hormones	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC01	ganirelix	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC02	cetrorelix	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC03	elagolix	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC54	relugolix, estradiol and norethisterone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02	CORTICOSTEROIDS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	H02A	CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA	Mineralocorticoids	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA01	aldosterone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA02	fludrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA03	desoxycortone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB	Glucocorticoids	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB01	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB02	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB03	fluocortolone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB04	methylprednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB05	paramethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB06	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB07	prednisone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB08	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB09	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB10	cortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB11	prednylidene	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB12	rimexolone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB13	deflazacort	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB14	cloprednol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB15	meprednisone	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB17	cortivazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02B	CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	H02BX	Corticosteroids for systemic use, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	H02BX01	methylprednisolone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	H02C	ANTIADRENAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA	Anticorticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA01	trilostane	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA02	osilodrostat	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA03	ketoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	H03	THYROID THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	H03A	THYROID PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA	Thyroid hormones	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA01	levothyroxine sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA02	liothyronine sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA03	combinations of levothyroxine and liothyronine	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA04	tiratricol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA05	thyroid gland preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	H03B	ANTITHYROID PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA	Thiouracils	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA01	methylthiouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA02	propylthiouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA03	benzylthiouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB	Sulfur-containing imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB01	carbimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB02	thiamazole	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB52	thiamazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BC	Perchlorates	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BC01	potassium perchlorate	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX	Other antithyroid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX01	diiodotyrosine	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX02	dibromotyrosine	WHO Anatomical Therapeutic Chemical classification
0‑L	H03C	IODINE THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	H03CA	Iodine therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	H04	PANCREATIC HORMONES	WHO Anatomical Therapeutic Chemical classification
0‑L	H04A	GLYCOGENOLYTIC HORMONES	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA	Glycogenolytic hormones	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA01	glucagon	WHO Anatomical Therapeutic Chemical classification
0‑L	H05	CALCIUM HOMEOSTASIS	WHO Anatomical Therapeutic Chemical classification
0‑L	H05A	PARATHYROID HORMONES AND ANALOGUES	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA	Parathyroid hormones and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA01	parathyroid gland extract	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA02	teriparatide	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA03	parathyroid hormone	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA04	abaloparatide	WHO Anatomical Therapeutic Chemical classification
0‑L	H05B	ANTI-PARATHYROID AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA	Calcitonin preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA01	calcitonin (salmon synthetic)	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA02	calcitonin (pork natural)	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA03	calcitonin (human synthetic)	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA04	elcatonin	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX	Other anti-parathyroid agents	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX01	cinacalcet	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX02	paricalcitol	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX03	doxercalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX04	etelcalcetide	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX05	calcifediol	WHO Anatomical Therapeutic Chemical classification
0‑L	J	ANTIINFECTIVES FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	J01	ANTIBACTERIALS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	J01A	TETRACYCLINES	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA	Tetracyclines	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA01	demeclocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA02	doxycycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA03	chlortetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA04	lymecycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA05	metacycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA06	oxytetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA07	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA08	minocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA09	rolitetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA10	penimepicycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA11	clomocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA12	tigecycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA13	eravacycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA14	sarecycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA15	omadacycline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA20	combinations of tetracyclines	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA56	oxytetracycline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01B	AMPHENICOLS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA	Amphenicols	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA01	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA02	thiamphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA52	thiamphenicol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA	Penicillins with extended spectrum	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA01	ampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA02	pivampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA03	carbenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA04	amoxicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA05	carindacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA06	bacampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA07	epicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA08	pivmecillinam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA09	azlocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA10	mezlocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA11	mecillinam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA12	piperacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA13	ticarcillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA14	metampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA15	talampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA16	sulbenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA17	temocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA18	hetacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA19	aspoxicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA51	ampicillin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE	Beta-lactamase sensitive penicillins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE01	benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE02	phenoxymethylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE03	propicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE04	azidocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE05	pheneticillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE06	penamecillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE07	clometocillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE08	benzathine benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE09	procaine benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE10	benzathine phenoxymethylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF	Beta-lactamase resistant penicillins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF01	dicloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF02	cloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF03	meticillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF04	oxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF05	flucloxacillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF06	nafcillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG	Beta-lactamase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG01	sulbactam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG02	tazobactam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR	Combinations of penicillins, incl. beta-lactamase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR01	ampicillin and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR02	amoxicillin and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR03	ticarcillin and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR04	sultamicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR05	piperacillin and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR50	combinations of penicillins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01D	OTHER BETA-LACTAM ANTIBACTERIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB	First-generation cephalosporins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB01	cefalexin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB02	cefaloridine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB03	cefalotin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB04	cefazolin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB05	cefadroxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB06	cefazedone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB07	cefatrizine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB08	cefapirin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB09	cefradine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB10	cefacetrile	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB11	cefroxadine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB12	ceftezole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC	Second-generation cephalosporins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC01	cefoxitin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC02	cefuroxime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC03	cefamandole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC04	cefaclor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC05	cefotetan	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC06	cefonicid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC07	cefotiam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC08	loracarbef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC09	cefmetazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC10	cefprozil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC11	ceforanide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC12	cefminox	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC13	cefbuperazone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC14	flomoxef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD	Third-generation cephalosporins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD01	cefotaxime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD02	ceftazidime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD03	cefsulodin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD04	ceftriaxone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD05	cefmenoxime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD06	latamoxef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD07	ceftizoxime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD08	cefixime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD09	cefodizime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD10	cefetamet	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD11	cefpiramide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD12	cefoperazone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD13	cefpodoxime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD14	ceftibuten	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD15	cefdinir	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD16	cefditoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD17	cefcapene	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD18	cefteram	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD51	cefotaxime and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD52	ceftazidime and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD54	ceftriaxone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD62	cefoperazone and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD63	ceftriaxone and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD64	cefpodoxime and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE	Fourth-generation cephalosporins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE01	cefepime	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE02	cefpirome	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE03	cefozopran	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF	Monobactams	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF01	aztreonam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF02	carumonam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH	Carbapenems	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH02	meropenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH03	ertapenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH04	doripenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH05	biapenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH06	tebipenem pivoxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH51	imipenem and cilastatin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH52	meropenem and vaborbactam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH55	panipenem and betamipron	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH56	imipenem, cilastatin and relebactam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI	Other cephalosporins and penems	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI01	ceftobiprole medocaril	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI02	ceftaroline fosamil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI03	faropenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI04	cefiderocol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI54	ceftolozane and beta-lactamase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01E	SULFONAMIDES AND TRIMETHOPRIM	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA	Trimethoprim and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA01	trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA02	brodimoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA03	iclaprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB	Short-acting sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB01	sulfaisodimidine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB02	sulfamethizole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB03	sulfadimidine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB04	sulfapyridine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB05	sulfafurazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB06	sulfanilamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB07	sulfathiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB08	sulfathiourea	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC	Intermediate-acting sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC01	sulfamethoxazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC02	sulfadiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC03	sulfamoxole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED	Long-acting sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED01	sulfadimethoxine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED02	sulfalene	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED03	sulfametomidine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED04	sulfametoxydiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED05	sulfamethoxypyridazine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED06	sulfaperin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED07	sulfamerazine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED08	sulfaphenazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED09	sulfamazone	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE	Combinations of sulfonamides and trimethoprim, incl. derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE01	sulfamethoxazole and trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE02	sulfadiazine and trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE03	sulfametrole and trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE04	sulfamoxole and trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE05	sulfadimidine and trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE06	sulfadiazine and tetroxoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE07	sulfamerazine and trimethoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01F	MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA	Macrolides	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA01	erythromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA02	spiramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA03	midecamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA05	oleandomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA06	roxithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA07	josamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA08	troleandomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA09	clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA10	azithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA11	miocamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA12	rokitamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA13	dirithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA14	flurithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA15	telithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA16	solithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF	Lincosamides	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF01	clindamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF02	lincomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG	Streptogramins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG01	pristinamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG02	quinupristin/dalfopristin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01G	AMINOGLYCOSIDE ANTIBACTERIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA	Streptomycins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA01	streptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA02	streptoduocin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB	Other aminoglycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB01	tobramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB03	gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB04	kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB05	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB06	amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB07	netilmicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB08	sisomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB09	dibekacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB10	ribostamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB11	isepamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB12	arbekacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB13	bekanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB14	plazomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01M	QUINOLONE ANTIBACTERIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA	Fluoroquinolones	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA01	ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA02	ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA03	pefloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA04	enoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA05	temafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA06	norfloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA07	lomefloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA08	fleroxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA09	sparfloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA10	rufloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA11	grepafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA12	levofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA13	trovafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA14	moxifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA15	gemifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA16	gatifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA17	prulifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA18	pazufloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA19	garenoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA21	sitafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA22	tosufloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA23	delafloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA24	levonadifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA25	lascufloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB	Other quinolones	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB01	rosoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB02	nalidixic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB03	piromidic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB04	pipemidic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB05	oxolinic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB06	cinoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB07	flumequine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB08	nemonoxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01R	COMBINATIONS OF ANTIBACTERIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA	Combinations of antibacterials	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA01	penicillins, combinations with other antibacterials	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA02	sulfonamides, combinations with other antibacterials (excl. trimethoprim)	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA03	cefuroxime and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA04	spiramycin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA05	levofloxacin and ornidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA06	cefepime and amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA07	azithromycin, fluconazole and secnidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA08	tetracycline and oleandomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA09	ofloxacin and ornidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA10	ciprofloxacin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA11	ciprofloxacin and tinidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA12	ciprofloxacin and ornidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA13	norfloxacin and tinidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01X	OTHER ANTIBACTERIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA	Glycopeptide antibacterials	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA01	vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA02	teicoplanin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA03	telavancin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA04	dalbavancin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA05	oritavancin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB	Polymyxins	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB01	colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB02	polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XC	Steroid antibacterials	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XC01	fusidic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD	Imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD01	metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD02	tinidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD03	ornidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE	Nitrofuran derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE01	nitrofurantoin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE02	nifurtoinol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE03	furazidin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE51	nitrofurantoin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX	Other antibacterials	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX01	fosfomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX02	xibornol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX03	clofoctol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX04	spectinomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX05	methenamine	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX06	mandelic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX07	nitroxoline	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX08	linezolid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX09	daptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX10	bacitracin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX11	tedizolid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX12	lefamulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02	ANTIMYCOTICS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	J02A	ANTIMYCOTICS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA01	amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA02	hachimycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB	Imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB01	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB02	ketoconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC	Triazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC01	fluconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC02	itraconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC03	voriconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC04	posaconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC05	isavuconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX	Other antimycotics for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX01	flucytosine	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX04	caspofungin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX05	micafungin	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX06	anidulafungin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04	ANTIMYCOBACTERIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J04A	DRUGS FOR TREATMENT OF TUBERCULOSIS	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA	Aminosalicylic acid and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA01	4-aminosalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA02	sodium aminosalicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA03	calcium aminosalicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB01	cycloserine	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB02	rifampicin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB03	rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB04	rifabutin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB05	rifapentine	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB06	enviomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB30	capreomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC	Hydrazides	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC01	isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC51	isoniazid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD	Thiocarbamide derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD01	protionamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD02	tiocarlide	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD03	ethionamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK	Other drugs for treatment of tuberculosis	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK01	pyrazinamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK02	ethambutol	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK03	terizidone	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK04	morinamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK05	bedaquiline	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK06	delamanid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK07	thioacetazone	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK08	pretomanid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM	Combinations of drugs for treatment of tuberculosis	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM01	streptomycin and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM02	rifampicin and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM03	ethambutol and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM04	thioacetazone and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM05	rifampicin, pyrazinamide and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM06	rifampicin, pyrazinamide, ethambutol and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM07	rifampicin, ethambutol and isoniazid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM08	isoniazid, sulfamethoxazole, trimethoprim and pyridoxine	WHO Anatomical Therapeutic Chemical classification
0‑L	J04B	DRUGS FOR TREATMENT OF LEPRA	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA	Drugs for treatment of lepra	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA01	clofazimine	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA02	dapsone	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA03	aldesulfone sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	J05	ANTIVIRALS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	J05A	DIRECT ACTING ANTIVIRALS	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AA	Thiosemicarbazones	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AA01	metisazone	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB01	aciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB02	idoxuridine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB03	vidarabine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB06	ganciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB09	famciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB11	valaciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB12	cidofovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB13	penciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB14	valganciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB15	brivudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC	Cyclic amines	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC02	rimantadine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC03	tromantadine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD	Phosphonic acid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD01	foscarnet	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD02	fosfonet	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE	Protease inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE01	saquinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE02	indinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE03	ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE04	nelfinavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE05	amprenavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE07	fosamprenavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE08	atazanavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE09	tipranavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE10	darunavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF	Nucleoside and nucleotide reverse transcriptase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF01	zidovudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF02	didanosine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF03	zalcitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF04	stavudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF05	lamivudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF06	abacavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF07	tenofovir disoproxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF08	adefovir dipivoxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF09	emtricitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF10	entecavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF11	telbivudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF12	clevudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF13	tenofovir alafenamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG	Non-nucleoside reverse transcriptase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG01	nevirapine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG02	delavirdine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG03	efavirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG04	etravirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG05	rilpivirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG06	doravirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH	Neuraminidase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH01	zanamivir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH02	oseltamivir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH03	peramivir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH04	laninamivir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ	Integrase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ01	raltegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ02	elvitegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ03	dolutegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ04	cabotegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP	Antivirals for treatment of HCV infections	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP01	ribavirin	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP02	telaprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP03	boceprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP04	faldaprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP05	simeprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP06	asunaprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP07	daclatasvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP08	sofosbuvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP09	dasabuvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP10	elbasvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP11	grazoprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP51	sofosbuvir and ledipasvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP52	dasabuvir, ombitasvir, paritaprevir and ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP53	ombitasvir, paritaprevir and ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP54	elbasvir and grazoprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP55	sofosbuvir and velpatasvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP56	sofosbuvir, velpatasvir and voxilaprevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP57	glecaprevir and pibrentasvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP58	daclatasvir, asunaprevir and beclabuvir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR	Antivirals for treatment of HIV infections, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR01	zidovudine and lamivudine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR02	lamivudine and abacavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR03	tenofovir disoproxil and emtricitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR04	zidovudine, lamivudine and abacavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR05	zidovudine, lamivudine and nevirapine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR06	emtricitabine, tenofovir disoproxil and efavirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR07	stavudine, lamivudine and nevirapine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR08	emtricitabine, tenofovir disoproxil and rilpivirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR09	emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR10	lopinavir and ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR11	lamivudine, tenofovir disoproxil and efavirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR12	lamivudine and tenofovir disoproxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR13	lamivudine, abacavir and dolutegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR14	darunavir and cobicistat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR15	atazanavir and cobicistat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR16	lamivudine and raltegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR17	emtricitabine and tenofovir alafenamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR18	emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR19	emtricitabine, tenofovir alafenamide and rilpivirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR20	emtricitabine, tenofovir alafenamide and bictegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR21	dolutegravir and rilpivirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR22	emtricitabine, tenofovir alafenamide, darunavir and cobicistat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR23	atazanavir and ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR24	lamivudine, tenofovir disoproxil and doravirine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR25	lamivudine and dolutegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR26	darunavir and ritonavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR27	lamivudine, tenofovir disoproxil and dolutegravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX	Other antivirals	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX01	moroxydine	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX02	lysozyme	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX05	inosine pranobex	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX06	pleconaril	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX07	enfuvirtide	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX09	maraviroc	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX10	maribavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX13	umifenovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX17	enisamium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX18	letermovir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX19	tilorone	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX21	pentanedioic acid imidazolyl ethanamide	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX23	ibalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX24	tecovirimat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX25	baloxavir marboxil	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX26	amenamevir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX27	favipiravir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX28	bulevirtide	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX29	fostemsavir	WHO Anatomical Therapeutic Chemical classification
0‑L	J06	IMMUNE SERA AND IMMUNOGLOBULINS	WHO Anatomical Therapeutic Chemical classification
0‑L	J06A	IMMUNE SERA	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA	Immune sera	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA01	diphtheria antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA02	tetanus antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA03	snake venom antiserum	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA04	botulinum antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA05	gas-gangrene sera	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA06	rabies serum	WHO Anatomical Therapeutic Chemical classification
0‑L	J06B	IMMUNOGLOBULINS	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA	Immunoglobulins, normal human	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA01	immunoglobulins, normal human, for extravascular adm.	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA02	immunoglobulins, normal human, for intravascular adm.	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB	Specific immunoglobulins	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB01	anti-D (rh) immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB02	tetanus immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB03	varicella/zoster immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB04	hepatitis B immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB05	rabies immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB06	rubella immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB07	vaccinia immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB08	staphylococcus immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB09	cytomegalovirus immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB10	diphtheria immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB11	hepatitis A immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB12	encephalitis, tick borne immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB13	pertussis immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB14	measles immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB15	mumps immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB16	palivizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB17	motavizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB18	raxibacumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB19	anthrax immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB21	bezlotoxumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB22	obiltoxaximab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC	Other immunoglobulins	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC01	nebacumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J07	VACCINES	WHO Anatomical Therapeutic Chemical classification
0‑L	J07A	BACTERIAL VACCINES	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AC	Anthrax vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AC01	anthrax antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AD	Brucellosis vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AD01	brucella antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE	Cholera vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE01	cholera, inactivated, whole cell	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE02	cholera, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE51	cholera, combinations with typhoid vaccine, inactivated, whole cell	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AF	Diphtheria vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AF01	diphtheria toxoid	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG	Haemophilus influenzae B vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG01	haemophilus influenzae B, purified antigen conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG51	haemophilus influenzae B, combinations with toxoids	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG52	haemophilus influenzae B, combinations with pertussis and toxoids	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG53	haemophilus influenzae B, combinations with meningococcus C, conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH	Meningococcal vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH01	meningococcus A, purified polysaccharides antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH02	other meningococcal monovalent purified polysaccharides antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH03	meningococcus A,C, bivalent purified polysaccharides antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH04	meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH05	other meningococcal polyvalent purified polysaccharides antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH06	meningococcus B, outer membrane vesicle vaccine	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH07	meningococcus C, purified polysaccharides antigen conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH08	meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH09	meningococcus B, multicomponent vaccine	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH10	meningococcus A, purified polysaccharides antigen conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ	Pertussis vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ01	pertussis, inactivated, whole cell	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ02	pertussis, purified antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ51	pertussis, inactivated, whole cell, combinations with toxoids	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ52	pertussis, purified antigen, combinations with toxoids	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AK	Plague vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AK01	plague, inactivated, whole cell	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL	Pneumococcal vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL01	pneumococcus, purified polysaccharides antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL02	pneumococcus, purified polysaccharides antigen conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL52	pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM	Tetanus vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM01	tetanus toxoid	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM51	tetanus toxoid, combinations with diphtheria toxoid	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM52	tetanus toxoid, combinations with tetanus immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AN	Tuberculosis vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AN01	tuberculosis, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP	Typhoid vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP01	typhoid, oral, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP02	typhoid, inactivated, whole cell	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP03	typhoid, purified polysaccharide antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP10	typhoid, combinations with paratyphi types	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AR	Typhus (exanthematicus) vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AR01	typhus exanthematicus, inactivated, whole cell	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AX	Other bacterial vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07B	VIRAL VACCINES	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA	Encephalitis vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA01	encephalitis, tick borne, inactivated, whole virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA02	encephalitis, Japanese, inactivated, whole virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA03	encephalitis, Japanese, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB	Influenza vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB01	influenza, inactivated, whole virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB02	influenza, inactivated, split virus or surface antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB03	influenza, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB04	influenza, virus like particles	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC	Hepatitis vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC01	hepatitis B, purified antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC02	hepatitis A, inactivated, whole virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD	Measles vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD01	measles, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD51	measles, combinations with mumps, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD52	measles, combinations with mumps and rubella, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD53	measles, combinations with rubella, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD54	measles, combinations with mumps, rubella and varicella, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BE	Mumps vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BE01	mumps, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF	Poliomyelitis vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF01	poliomyelitis oral, monovalent, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF02	poliomyelitis oral, trivalent, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF03	poliomyelitis, trivalent, inactivated, whole virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF04	poliomyelitis oral, bivalent, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BG	Rabies vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BG01	rabies, inactivated, whole virus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH	Rota virus diarrhea vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH01	rota virus, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH02	rota virus, pentavalent, live, reassorted	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ	Rubella vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ01	rubella, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ51	rubella, combinations with mumps, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK	Varicella zoster vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK01	varicella, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK02	zoster, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK03	zoster, purified antigen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BL	Yellow fever vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BL01	yellow fever, live attenuated	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM	Papillomavirus vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM01	papillomavirus (human types 6, 11, 16, 18)	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM02	papillomavirus (human types 16, 18)	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM03	papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX	Other viral vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX01	smallpox vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX02	ebola vaccines	WHO Anatomical Therapeutic Chemical classification
0‑L	J07C	BACTERIAL AND VIRAL VACCINES, COMBINED	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA	Bacterial and viral vaccines, combined	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA01	diphtheria-poliomyelitis-tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA02	diphtheria-pertussis-poliomyelitis-tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA03	diphtheria-rubella-tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA04	haemophilus influenzae B and poliomyelitis	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA05	diphtheria-hepatitis B-pertussis-tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA06	diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA07	diphtheria-hepatitis B-tetanus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA08	haemophilus influenzae B and hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA09	diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA10	typhoid-hepatitis A	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA11	diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA12	diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA13	diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C	WHO Anatomical Therapeutic Chemical classification
0‑L	J07X	OTHER VACCINES	WHO Anatomical Therapeutic Chemical classification
0‑L	L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L01	ANTINEOPLASTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L01A	ALKYLATING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA	Nitrogen mustard analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA01	cyclophosphamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA02	chlorambucil	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA03	melphalan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA05	chlormethine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA06	ifosfamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA07	trofosfamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA08	prednimustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA09	bendamustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB	Alkyl sulfonates	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB01	busulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB02	treosulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB03	mannosulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC	Ethylene imines	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC01	thiotepa	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC02	triaziquone	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC03	carboquone	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD	Nitrosoureas	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD01	carmustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD02	lomustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD03	semustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD04	streptozocin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD05	fotemustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD06	nimustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD07	ranimustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD08	uramustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AG	Epoxides	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AG01	etoglucid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX	Other alkylating agents	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX01	mitobronitol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX02	pipobroman	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX03	temozolomide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX04	dacarbazine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01B	ANTIMETABOLITES	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA	Folic acid analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA01	methotrexate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA03	raltitrexed	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA04	pemetrexed	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA05	pralatrexate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB	Purine analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB02	mercaptopurine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB03	tioguanine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB04	cladribine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB05	fludarabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB06	clofarabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB07	nelarabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC	Pyrimidine analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC01	cytarabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC02	fluorouracil	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC03	tegafur	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC04	carmofur	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC05	gemcitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC06	capecitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC07	azacitidine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC08	decitabine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC09	floxuridine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC52	fluorouracil, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC53	tegafur, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC59	trifluridine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	L01C	PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA	Vinca alkaloids and analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA01	vinblastine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA02	vincristine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA03	vindesine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA04	vinorelbine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA05	vinflunine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA06	vintafolide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB	Podophyllotoxin derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB01	etoposide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB02	teniposide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CC	Colchicine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CC01	demecolcine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD	Taxanes	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD01	paclitaxel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD02	docetaxel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD03	paclitaxel poliglumex	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD04	cabazitaxel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE	Topoisomerase 1 (TOP1) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE01	topotecan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE02	irinotecan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE03	etirinotecan pegol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE04	belotecan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CX	Other plant alkaloids and natural products	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CX01	trabectedin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01D	CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DA	Actinomycines	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DA01	dactinomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB	Anthracyclines and related substances	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB01	doxorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB02	daunorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB03	epirubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB04	aclarubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB05	zorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB06	idarubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB07	mitoxantrone	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB08	pirarubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB09	valrubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB10	amrubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB11	pixantrone	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC	Other cytotoxic antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC01	bleomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC02	plicamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC03	mitomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC04	ixabepilone	WHO Anatomical Therapeutic Chemical classification
0‑L	L01E	PROTEIN KINASE INHIBITORS	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA	BCR-ABL tyrosine kinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA01	imatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA02	dasatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA03	nilotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA04	bosutinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA05	ponatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB01	gefitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB02	erlotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB03	afatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB04	osimertinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB05	rociletinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB06	olmutinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB07	dacomitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB08	icotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC	B-Raf serine-threonine kinase (BRAF) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC01	vemurafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC02	dabrafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC03	encorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED	Anaplastic lymphoma kinase (ALK) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED01	crizotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED02	ceritinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED03	alectinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED04	brigatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED05	lorlatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE	Mitogen-activated protein kinase (MEK) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE01	trametinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE02	cobimetinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE03	binimetinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE04	selumetinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF	Cyclin-dependent kinase (CDK) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF01	palbociclib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF02	ribociclib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF03	abemaciclib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG	Mammalian target of rapamycin (mTOR) kinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG01	temsirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG02	everolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG03	ridaforolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH	Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH01	lapatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH02	neratinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH03	tucatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ	Janus-associated kinase (JAK) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ01	ruxolitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ02	fedratinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK	Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK01	axitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK02	cediranib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK03	tivozanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL	Bruton's tyrosine kinase (BTK) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL01	ibrutinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL02	acalabrutinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL03	zanubrutinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM	Phosphatidylinositol-3-kinase (Pi3K) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM01	idelalisib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM02	copanlisib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM03	alpelisib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM04	duvelisib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX	Other protein kinase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX01	sunitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX02	sorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX03	pazopanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX04	vandetanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX05	regorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX06	masitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX07	cabozantinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX08	lenvatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX09	nintedanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX10	midostaurin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX11	quizartinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX12	larotrectinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX13	gilteritinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX14	entrectinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX15	pexidartinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX16	erdafitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX17	capmatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX18	avapritinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX19	ripretinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX20	pemigatinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX21	tepotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01X	OTHER ANTINEOPLASTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA	Platinum compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA01	cisplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA02	carboplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA03	oxaliplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA04	satraplatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA05	polyplatillen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XB	Methylhydrazines	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XB01	procarbazine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC	Monoclonal antibodies	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC01	edrecolomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC02	rituximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC03	trastuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC05	gemtuzumab ozogamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC06	cetuximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC07	bevacizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC08	panitumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC09	catumaxomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC10	ofatumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC11	ipilimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC12	brentuximab vedotin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC13	pertuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC14	trastuzumab emtansine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC15	obinutuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC16	dinutuximab beta	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC17	nivolumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC18	pembrolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC19	blinatumomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC21	ramucirumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC22	necitumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC23	elotuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC24	daratumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC25	mogamulizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC26	inotuzumab ozogamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC27	olaratumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC28	durvalumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC29	bermekimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC31	avelumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC32	atezolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC33	cemiplimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC34	moxetumomab pasudotox	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC35	tafasitamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC36	enfortumab vedotin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC37	polatuzumab vedotin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC38	isatuximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC39	belantamab mafodotin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC40	dostarlimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XC41	trastuzumab deruxtecan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD	Sensitizers used in photodynamic/radiation therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD01	porfimer sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD03	methyl aminolevulinate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD04	aminolevulinic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD05	temoporfin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD06	efaproxiral	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD07	padeliporfin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF	Retinoids for cancer treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF01	tretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF02	alitretinoin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF03	bexarotene	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG	Proteasome inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG01	bortezomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG02	carfilzomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG03	ixazomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH	Histone deacetylase (HDAC) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH01	vorinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH02	romidepsin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH03	panobinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH04	belinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH05	entinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ	Hedgehog pathway inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ01	vismodegib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ02	sonidegib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ03	glasdegib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK	Poly (ADP-ribose) polymerase (PARP) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK01	olaparib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK02	niraparib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK03	rucaparib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK04	talazoparib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK05	veliparib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX	Other antineoplastic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX01	amsacrine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX02	asparaginase	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX03	altretamine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX05	hydroxycarbamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX07	lonidamine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX08	pentostatin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX10	masoprocol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX11	estramustine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX16	mitoguazone	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX18	tiazofurine	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX23	mitotane	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX24	pegaspargase	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX27	arsenic trioxide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX29	denileukin diftitox	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX33	celecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX35	anagrelide	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX36	oblimersen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX37	sitimagene ceradenovec	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX40	omacetaxine mepesuccinate	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX41	eribulin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX44	aflibercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX51	talimogene laherparepvec	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX52	venetoclax	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX53	vosaroxin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX57	plitidepsin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX58	epacadostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX59	enasidenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX62	ivosidenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX66	selinexor	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX67	tagraxofusp	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX69	lurbinectedin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX70	axicabtagene ciloleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX71	tisagenlecleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XY	Combinations of antineoplastic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XY01	cytarabine and daunorubicin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XY02	pertuzumab and trastuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L02	ENDOCRINE THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	L02A	HORMONES AND RELATED AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA	Estrogens	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA01	diethylstilbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA02	polyestradiol phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA03	ethinylestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA04	fosfestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB	Progestogens	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB01	megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB02	medroxyprogesterone	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB03	gestonorone	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE	Gonadotropin releasing hormone analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE01	buserelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE02	leuprorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE03	goserelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE04	triptorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE05	histrelin	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE51	leuprorelin and bicalutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AX	Other hormones	WHO Anatomical Therapeutic Chemical classification
0‑L	L02B	HORMONE ANTAGONISTS AND RELATED AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA	Anti-estrogens	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA01	tamoxifen	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA02	toremifene	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA03	fulvestrant	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB	Anti-androgens	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB01	flutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB02	nilutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB03	bicalutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB04	enzalutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB05	apalutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB06	darolutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG	Aromatase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG01	aminoglutethimide	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG02	formestane	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG03	anastrozole	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG04	letrozole	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG05	vorozole	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG06	exemestane	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX	Other hormone antagonists and related agents	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX01	abarelix	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX02	degarelix	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX03	abiraterone	WHO Anatomical Therapeutic Chemical classification
0‑L	L03	IMMUNOSTIMULANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L03A	IMMUNOSTIMULANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA	Colony stimulating factors	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA02	filgrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA03	molgramostim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA09	sargramostim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA10	lenograstim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA12	ancestim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA13	pegfilgrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA14	lipegfilgrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA15	balugrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA16	empegfilgrastim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA17	pegteograstim	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB	Interferons	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB01	interferon alfa natural	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB02	interferon beta natural	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB03	interferon gamma	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB04	interferon alfa-2a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB05	interferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB06	interferon alfa-n1	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB07	interferon beta-1a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB08	interferon beta-1b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB09	interferon alfacon-1	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB10	peginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB11	peginterferon alfa-2a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB12	albinterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB13	peginterferon beta-1a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB14	cepeginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB15	ropeginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB60	peginterferon alfa-2b, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB61	peginterferon alfa-2a, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC	Interleukins	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC01	aldesleukin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC02	oprelvekin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX	Other immunostimulants	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX01	lentinan	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX02	roquinimex	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX03	BCG vaccine	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX04	pegademase	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX05	pidotimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX07	poly I:C	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX08	poly ICLC	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX09	thymopentin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX10	immunocyanin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX11	tasonermin	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX12	melanoma vaccine	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX13	glatiramer acetate	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX14	histamine dihydrochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX15	mifamurtide	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX16	plerixafor	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX17	sipuleucel-T	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX18	cridanimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX19	dasiprotimut-T	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX21	elapegademase	WHO Anatomical Therapeutic Chemical classification
0‑L	L04	IMMUNOSUPPRESSANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L04A	IMMUNOSUPPRESSANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA	Selective immunosuppressants	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA02	muromonab-CD3	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA03	antilymphocyte immunoglobulin (horse)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA04	antithymocyte immunoglobulin (rabbit)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA06	mycophenolic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA10	sirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA13	leflunomide	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA15	alefacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA18	everolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA19	gusperimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA21	efalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA22	abetimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA23	natalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA24	abatacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA25	eculizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA26	belimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA27	fingolimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA28	belatacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA29	tofacitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA31	teriflunomide	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA32	apremilast	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA33	vedolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA34	alemtuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA35	begelomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA36	ocrelizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA37	baricitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA38	ozanimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA39	emapalumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA40	cladribine	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA41	imlifidase	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA42	siponimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA43	ravulizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA44	upadacitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA45	filgotinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA46	itacitinib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA47	inebilizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB	Tumor necrosis factor alpha (TNF-alpha) inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB01	etanercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB02	infliximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB03	afelimomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB04	adalimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB05	certolizumab pegol	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB06	golimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB07	opinercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC	Interleukin inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC01	daclizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC02	basiliximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC03	anakinra	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC04	rilonacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC05	ustekinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC07	tocilizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC08	canakinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC09	briakinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC10	secukinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC11	siltuximab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC12	brodalumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC13	ixekizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC14	sarilumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC15	sirukumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC16	guselkumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC17	tildrakizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC18	risankizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC19	satralizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD	Calcineurin inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD01	ciclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD02	tacrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD03	voclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX	Other immunosuppressants	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX01	azathioprine	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX02	thalidomide	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX03	methotrexate	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX04	lenalidomide	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX05	pirfenidone	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX06	pomalidomide	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX07	dimethyl fumarate	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX08	darvadstrocel	WHO Anatomical Therapeutic Chemical classification
0‑L	M	MUSCULO-SKELETAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA	Butylpyrazolidines	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA01	phenylbutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA02	mofebutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA03	oxyphenbutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA05	clofezone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA06	kebuzone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB	Acetic acid derivatives and related substances	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB01	indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB02	sulindac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB03	tolmetin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB04	zomepirac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB05	diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB06	alclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB07	bumadizone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB08	etodolac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB09	lonazolac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB10	fentiazac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB11	acemetacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB12	difenpiramide	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB13	oxametacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB14	proglumetacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB15	ketorolac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB16	aceclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB17	bufexamac	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB51	indometacin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB55	diclofenac, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC	Oxicams	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC01	piroxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC02	tenoxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC04	droxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC05	lornoxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC06	meloxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC56	meloxicam, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE	Propionic acid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE01	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE02	naproxen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE03	ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE04	fenoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE05	fenbufen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE06	benoxaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE07	suprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE08	pirprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE09	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE10	indoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE11	tiaprofenic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE12	oxaprozin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE13	ibuproxam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE14	dexibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE15	flunoxaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE16	alminoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE17	dexketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE18	naproxcinod	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE51	ibuprofen, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE52	naproxen and esomeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE53	ketoprofen, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE56	naproxen and misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG	Fenamates	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG01	mefenamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG02	tolfenamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG03	flufenamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG04	meclofenamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH	Coxibs	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH01	celecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH02	rofecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH03	valdecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH04	parecoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH05	etoricoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH06	lumiracoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH07	polmacoxib	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX	Other antiinflammatory and antirheumatic agents, non-steroids	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX01	nabumetone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX02	niflumic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX04	azapropazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX05	glucosamine	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX07	benzydamine	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX12	glucosaminoglycan polysulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX13	proquazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX14	orgotein	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX17	nimesulide	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX18	feprazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX21	diacerein	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX22	morniflumate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX23	tenidap	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX24	oxaceprol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX25	chondroitin sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX26	avocado and soyabean oil, unsaponifiables	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX68	feprazone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01B	ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA	Antiinflammatory/antirheumatic agents in combination with corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA01	phenylbutazone and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA02	dipyrocetyl and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA03	acetylsalicylic acid and corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BX	Other antiinflammatory/antirheumatic agents in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	M01C	SPECIFIC ANTIRHEUMATIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CA	Quinolines	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CA03	oxycinchophen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB	Gold preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB01	sodium aurothiomalate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB02	sodium aurotiosulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB03	auranofin	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB04	aurothioglucose	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB05	aurotioprol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC	Penicillamine and similar agents	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC01	penicillamine	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC02	bucillamine	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CX	Other specific antirheumatic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA	Antiinflammatory preparations, non-steroids for topical use	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA01	phenylbutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA02	mofebutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA03	clofezone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA04	oxyphenbutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA05	benzydamine	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA06	etofenamate	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA07	piroxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA08	felbinac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA09	bufexamac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA10	ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA11	bendazac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA12	naproxen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA13	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA14	fentiazac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA15	diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA16	feprazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA17	niflumic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA18	meclofenamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA19	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA21	tolmetin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA22	suxibuzone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA23	indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA24	nifenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA25	aceclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA26	nimesulide	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA27	dexketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA28	piketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA29	esflurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB	Capsaicin and similar agents	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB01	capsaicin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB02	zucapsaicin	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AC	Preparations with salicylic acid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX	Other topical products for joint and muscular pain	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX02	tolazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX03	dimethyl sulfoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX05	idrocilamide	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX06	tolperisone	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX10	various	WHO Anatomical Therapeutic Chemical classification
0‑L	M03	MUSCLE RELAXANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	M03A	MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA	Curare alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA01	alcuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA02	tubocurarine	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA04	dimethyltubocurarine	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AB	Choline derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AB01	suxamethonium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC	Other quaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC01	pancuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC02	gallamine	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC03	vecuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC04	atracurium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC05	hexafluronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC06	pipecuronium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC07	doxacurium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC08	fazadinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC09	rocuronium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC10	mivacurium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC11	cisatracurium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AX	Other muscle relaxants, peripherally acting agents	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AX01	botulinum toxin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03B	MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA	Carbamic acid esters	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA01	phenprobamate	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA02	carisoprodol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA03	methocarbamol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA04	styramate	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA05	febarbamate	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA51	phenprobamate, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA52	carisoprodol, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA53	methocarbamol, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA71	phenprobamate, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA72	carisoprodol, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA73	methocarbamol, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB	Oxazol, thiazine, and triazine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB02	chlormezanone	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB03	chlorzoxazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB52	chlormezanone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB53	chlorzoxazone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB72	chlormezanone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB73	chlorzoxazone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC	Ethers, chemically close to antihistamines	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC01	orphenadrine (citrate)	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC51	orphenadrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX	Other centrally acting agents	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX01	baclofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX02	tizanidine	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX03	pridinol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX04	tolperisone	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX05	thiocolchicoside	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX06	mephenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX07	tetrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX08	cyclobenzaprine	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX09	eperisone	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX30	fenyramidol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX55	thiocolchicoside, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M03C	MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	M03CA	Dantrolene and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	M03CA01	dantrolene	WHO Anatomical Therapeutic Chemical classification
0‑L	M04	ANTIGOUT PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	M04A	ANTIGOUT PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA	Preparations inhibiting uric acid production	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA01	allopurinol	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA02	tisopurine	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA03	febuxostat	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA51	allopurinol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB	Preparations increasing uric acid excretion	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB01	probenecid	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB02	sulfinpyrazone	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB03	benzbromarone	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB04	isobromindione	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB05	lesinurad	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC	Preparations with no effect on uric acid metabolism	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC01	colchicine	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC02	cinchophen	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX	Other antigout preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX01	urate oxidase	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX02	pegloticase	WHO Anatomical Therapeutic Chemical classification
0‑L	M05	DRUGS FOR TREATMENT OF BONE DISEASES	WHO Anatomical Therapeutic Chemical classification
0‑L	M05B	DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA	Bisphosphonates	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA01	etidronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA02	clodronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA03	pamidronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA04	alendronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA05	tiludronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA06	ibandronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA07	risedronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA08	zoledronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB	Bisphosphonates, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB01	etidronic acid and calcium, sequential	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB02	risedronic acid and calcium, sequential	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB03	alendronic acid and colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB04	risedronic acid, calcium and colecalciferol, sequential	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB05	alendronic acid, calcium and colecalciferol, sequential	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB06	alendronic acid and alfacalcidol, sequential	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB07	risedronic acid and colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB08	zoledronic acid, calcium and colecalciferol, sequential	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB09	ibandronic acid and colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC	Bone morphogenetic proteins	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC01	dibotermin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC02	eptotermin alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX	Other drugs affecting bone structure and mineralization	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX01	ipriflavone	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX02	aluminium chlorohydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX03	strontium ranelate	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX04	denosumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX05	burosumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX06	romosozumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX53	strontium ranelate and colecalciferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M09	OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	M09A	OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA	Quinine and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA01	hydroquinine	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA72	quinine, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB	Enzymes	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB01	chymopapain	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB02	collagenase clostridium histolyticum	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB03	bromelains	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB52	trypsin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX	Other drugs for disorders of the musculo-skeletal system	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX01	hyaluronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX02	chondrocytes, autologous	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX03	ataluren	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX04	drisapersen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX05	aceneuramic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX06	eteplirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX07	nusinersen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX08	golodirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX09	onasemnogene abeparvovec	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX10	risdiplam	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX11	palovarotene	WHO Anatomical Therapeutic Chemical classification
0‑L	N	NERVOUS SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	N01	ANESTHETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N01A	ANESTHETICS, GENERAL	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA	Ethers	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA01	diethyl ether	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA02	vinyl ether	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB	Halogenated hydrocarbons	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB01	halothane	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB02	chloroform	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB04	enflurane	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB05	trichloroethylene	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB06	isoflurane	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB07	desflurane	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB08	sevoflurane	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF	Barbiturates, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF01	methohexital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF02	hexobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF03	thiopental	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AG	Barbiturates in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AG01	narcobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH	Opioid anesthetics	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH01	fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH02	alfentanil	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH03	sufentanil	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH04	phenoperidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH05	anileridine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH06	remifentanil	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH51	fentanyl, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX	Other general anesthetics	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX03	ketamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX04	propanidid	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX05	alfaxalone	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX07	etomidate	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX10	propofol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX11	sodium oxybate	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX13	nitrous oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX14	esketamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX15	xenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX63	nitrous oxide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01B	ANESTHETICS, LOCAL	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA	Esters of aminobenzoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA01	metabutethamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA02	procaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA03	tetracaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA04	chloroprocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA05	benzocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA52	procaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA53	tetracaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB	Amides	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB01	bupivacaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB02	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB03	mepivacaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB04	prilocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB05	butanilicaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB06	cinchocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB07	etidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB08	articaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB09	ropivacaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB10	levobupivacaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB51	bupivacaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB52	lidocaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB53	mepivacaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB54	prilocaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB57	etidocaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB58	articaine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB59	bupivacaine and meloxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BC	Esters of benzoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BC01	cocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX	Other local anesthetics	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX01	ethyl chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX02	dyclonine	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX03	phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX04	capsaicin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02	ANALGESICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N02A	OPIOIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA	Natural opium alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA01	morphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA02	opium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA03	hydromorphone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA04	nicomorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA05	oxycodone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA08	dihydrocodeine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA10	papaveretum	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA11	oxymorphone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA51	morphine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA53	hydromorphone and naloxone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA55	oxycodone and naloxone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA56	oxycodone and naltrexone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA58	dihydrocodeine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA59	codeine, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA79	codeine, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB	Phenylpiperidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB01	ketobemidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB02	pethidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB03	fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB52	pethidine, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB72	pethidine, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC	Diphenylpropylamine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC01	dextromoramide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC03	piritramide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC04	dextropropoxyphene	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC05	bezitramide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC52	methadone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC54	dextropropoxyphene, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC74	dextropropoxyphene, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD	Benzomorphan derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD01	pentazocine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD02	phenazocine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AE	Oripavine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AE01	buprenorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF	Morphinan derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF01	butorphanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF02	nalbuphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG	Opioids in combination with antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG01	morphine and antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG02	ketobemidone and antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG03	pethidine and antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG04	hydromorphone and antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ	Opioids in combination with non-opioid analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ01	dihydrocodeine and paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ02	dihydrocodeine and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ03	dihydrocodeine and other non-opioid analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ06	codeine and paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ07	codeine and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ08	codeine and ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ09	codeine and other non-opioid analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ13	tramadol and paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ14	tramadol and dexketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ15	tramadol and other non-opioid analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ17	oxycodone and paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ18	oxycodone and acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ19	oxycodone and ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX	Other opioids	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX01	tilidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX02	tramadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX03	dezocine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX05	meptazinol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX06	tapentadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02B	OTHER ANALGESICS AND ANTIPYRETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA	Salicylic acid and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA01	acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA02	aloxiprin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA03	choline salicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA04	sodium salicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA05	salicylamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA06	salsalate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA07	ethenzamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA08	morpholine salicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA09	dipyrocetyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA10	benorilate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA11	diflunisal	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA12	potassium salicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA14	guacetisal	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA15	carbasalate calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA16	imidazole salicylate	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA51	acetylsalicylic acid, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA55	salicylamide, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA57	ethenzamide, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA59	dipyrocetyl, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA65	carbasalate calcium combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA71	acetylsalicylic acid, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA75	salicylamide, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA77	ethenzamide, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA79	dipyrocetyl, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB	Pyrazolones	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB01	phenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB02	metamizole sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB03	aminophenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB04	propyphenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB05	nifenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB51	phenazone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB52	metamizole sodium, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB53	aminophenazone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB54	propyphenazone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB71	phenazone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB72	metamizole sodium, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB73	aminophenazone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB74	propyphenazone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE	Anilides	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE01	paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE03	phenacetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE04	bucetin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE05	propacetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE51	paracetamol, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE53	phenacetin, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE54	bucetin, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE71	paracetamol, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE73	phenacetin, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE74	bucetin, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG	Other analgesics and antipyretics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG02	rimazolium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG03	glafenine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG04	floctafenine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG05	viminol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG06	nefopam	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG07	flupirtine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG08	ziconotide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG09	methoxyflurane	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG10	cannabinoids	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG11	mirogabalin	WHO Anatomical Therapeutic Chemical classification
0‑L	N02C	ANTIMIGRAINE PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA	Ergot alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA01	dihydroergotamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA02	ergotamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA04	methysergide	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA07	lisuride	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA51	dihydroergotamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA52	ergotamine, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA72	ergotamine, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CB	Corticosteroid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CB01	flumedroxone	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC	Selective serotonin (5HT1) agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC01	sumatriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC02	naratriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC03	zolmitriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC04	rizatriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC05	almotriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC06	eletriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC07	frovatriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD	Calcitonin gene-related peptide (CGRP) antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD01	erenumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD02	galcanezumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD03	fremanezumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX	Other antimigraine preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX01	pizotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX02	clonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX03	iprazochrome	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX05	dimetotiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX06	oxetorone	WHO Anatomical Therapeutic Chemical classification
0‑L	N03	ANTIEPILEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N03A	ANTIEPILEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA	Barbiturates and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA01	methylphenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA02	phenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA03	primidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA04	barbexaclone	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA30	metharbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB	Hydantoin derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB01	ethotoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB02	phenytoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB03	amino(diphenylhydantoin) valeric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB04	mephenytoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB05	fosphenytoin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB52	phenytoin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB54	mephenytoin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC	Oxazolidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC01	paramethadione	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC02	trimethadione	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC03	ethadione	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD	Succinimide derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD01	ethosuximide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD02	phensuximide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD03	mesuximide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD51	ethosuximide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AE	Benzodiazepine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AE01	clonazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF	Carboxamide derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF01	carbamazepine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF02	oxcarbazepine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF03	rufinamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF04	eslicarbazepine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG	Fatty acid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG01	valproic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG02	valpromide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG03	aminobutyric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG04	vigabatrin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG05	progabide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG06	tiagabine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX	Other antiepileptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX03	sultiame	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX07	phenacemide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX09	lamotrigine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX10	felbamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX11	topiramate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX12	gabapentin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX13	pheneturide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX14	levetiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX15	zonisamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX16	pregabalin	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX17	stiripentol	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX18	lacosamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX19	carisbamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX21	retigabine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX22	perampanel	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX23	brivaracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX24	cannabidiol	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX25	cenobamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX26	fenfluramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX30	beclamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N04	ANTI-PARKINSON DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	N04A	ANTICHOLINERGIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA	Tertiary amines	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA01	trihexyphenidyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA02	biperiden	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA03	metixene	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA04	procyclidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA05	profenamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA08	dexetimide	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA09	phenglutarimide	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA10	mazaticol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA11	bornaprine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA12	tropatepine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB	Ethers chemically close to antihistamines	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB01	etanautine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB02	orphenadrine (chloride)	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC	Ethers of tropine or tropine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC01	benzatropine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC30	etybenzatropine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04B	DOPAMINERGIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA	Dopa and dopa derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA01	levodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA02	levodopa and decarboxylase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA03	levodopa, decarboxylase inhibitor and COMT inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA04	melevodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA05	melevodopa and decarboxylase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA06	etilevodopa and decarboxylase inhibitor	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BB	Adamantane derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BB01	amantadine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC	Dopamine agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC01	bromocriptine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC02	pergolide	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC03	dihydroergocryptine mesylate	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC04	ropinirole	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC05	pramipexole	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC06	cabergoline	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC07	apomorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC08	piribedil	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC09	rotigotine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD	Monoamine oxidase B inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD01	selegiline	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD02	rasagiline	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD03	safinamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX	Other dopaminergic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX01	tolcapone	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX02	entacapone	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX03	budipine	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX04	opicapone	WHO Anatomical Therapeutic Chemical classification
0‑L	N04C	OTHER ANTIPARKINSON DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	N04CX	Other antiparkinson drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	N04CX01	istradefyllin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05	PSYCHOLEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N05A	ANTIPSYCHOTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA	Phenothiazines with aliphatic side-chain	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA01	chlorpromazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA02	levomepromazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA03	promazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA04	acepromazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA05	triflupromazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA06	cyamemazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA07	chlorproethazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB	Phenothiazines with piperazine structure	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB01	dixyrazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB02	fluphenazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB03	perphenazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB04	prochlorperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB05	thiopropazate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB06	trifluoperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB07	acetophenazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB08	thioproperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB09	butaperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB10	perazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC	Phenothiazines with piperidine structure	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC01	periciazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC02	thioridazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC03	mesoridazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC04	pipotiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD	Butyrophenone derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD01	haloperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD02	trifluperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD03	melperone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD04	moperone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD05	pipamperone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD06	bromperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD07	benperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD08	droperidol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD09	fluanisone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE	Indole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE01	oxypertine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE02	molindone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE03	sertindole	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE04	ziprasidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE05	lurasidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF	Thioxanthene derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF01	flupentixol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF02	clopenthixol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF03	chlorprothixene	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF04	tiotixene	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF05	zuclopenthixol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG	Diphenylbutylpiperidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG01	fluspirilene	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG02	pimozide	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG03	penfluridol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH	Diazepines, oxazepines, thiazepines and oxepines	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH01	loxapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH02	clozapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH03	olanzapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH04	quetiapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH05	asenapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH06	clotiapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL	Benzamides	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL01	sulpiride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL02	sultopride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL03	tiapride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL04	remoxipride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL05	amisulpride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL06	veralipride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL07	levosulpiride	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AN	Lithium	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AN01	lithium	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX	Other antipsychotics	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX07	prothipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX08	risperidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX10	mosapramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX11	zotepine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX12	aripiprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX13	paliperidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX14	iloperidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX15	cariprazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX16	brexpiprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX17	pimavanserin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05B	ANXIOLYTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA	Benzodiazepine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA01	diazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA02	chlordiazepoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA03	medazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA04	oxazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA05	potassium clorazepate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA06	lorazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA07	adinazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA08	bromazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA09	clobazam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA10	ketazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA11	prazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA12	alprazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA13	halazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA14	pinazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA15	camazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA16	nordazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA17	fludiazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA18	ethyl loflazepate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA19	etizolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA21	clotiazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA22	cloxazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA23	tofisopam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA24	bentazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA56	lorazepam, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB	Diphenylmethane derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB01	hydroxyzine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB02	captodiame	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB51	hydroxyzine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC	Carbamates	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC01	meprobamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC03	emylcamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC04	mebutamate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC51	meprobamate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BD	Dibenzo-bicyclo-octadiene derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BD01	benzoctamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BE	Azaspirodecanedione derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BE01	buspirone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX	Other anxiolytics	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX01	mephenoxalone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX02	gedocarnil	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX03	etifoxine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX04	fabomotizole	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX05	Lavandulae aetheroleum	WHO Anatomical Therapeutic Chemical classification
0‑L	N05C	HYPNOTICS AND SEDATIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA	Barbiturates, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA01	pentobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA02	amobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA03	butobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA04	barbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA05	aprobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA06	secobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA07	talbutal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA08	vinylbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA09	vinbarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA10	cyclobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA11	heptabarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA12	reposal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA15	methohexital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA16	hexobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA19	thiopental	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA20	etallobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA21	allobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA22	proxibarbal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB	Barbiturates, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB01	combinations of barbiturates	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB02	barbiturates in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC	Aldehydes and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC01	chloral hydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC02	chloralodol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC03	acetylglycinamide chloral hydrate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC04	dichloralphenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC05	paraldehyde	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD	Benzodiazepine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD01	flurazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD02	nitrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD03	flunitrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD04	estazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD05	triazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD06	lormetazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD07	temazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD08	midazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD09	brotizolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD10	quazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD11	loprazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD12	doxefazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD13	cinolazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD14	remimazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD15	nimetazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE	Piperidinedione derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE01	glutethimide	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE02	methyprylon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE03	pyrithyldione	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF	Benzodiazepine related drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF01	zopiclone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF02	zolpidem	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF03	zaleplon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF04	eszopiclone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH	Melatonin receptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH01	melatonin	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH02	ramelteon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH03	tasimelteon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM	Other hypnotics and sedatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM01	methaqualone	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM02	clomethiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM03	bromisoval	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM04	carbromal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM05	scopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM06	propiomazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM07	triclofos	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM08	ethchlorvynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM09	Valerianae radix	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM10	hexapropymate	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM11	bromides	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM12	apronal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM13	valnoctamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM15	methylpentynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM16	niaprazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM18	dexmedetomidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM19	suvorexant	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX	Hypnotics and sedatives in combination, excl. barbiturates	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX01	meprobamate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX02	methaqualone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX03	methylpentynol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX04	clomethiazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX05	emepronium, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX06	dipiperonylaminoethanol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N06	PSYCHOANALEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N06A	ANTIDEPRESSANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA	Non-selective monoamine reuptake inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA01	desipramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA02	imipramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA03	imipramine oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA04	clomipramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA05	opipramol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA06	trimipramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA07	lofepramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA08	dibenzepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA09	amitriptyline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA10	nortriptyline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA11	protriptyline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA12	doxepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA13	iprindole	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA14	melitracen	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA15	butriptyline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA16	dosulepin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA17	amoxapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA18	dimetacrine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA19	amineptine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA21	maprotiline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA23	quinupramine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB	Selective serotonin reuptake inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB02	zimeldine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB03	fluoxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB04	citalopram	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB05	paroxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB06	sertraline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB07	alaproclate	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB08	fluvoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB09	etoperidone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB10	escitalopram	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF	Monoamine oxidase inhibitors, non-selective	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF01	isocarboxazid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF02	nialamide	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF03	phenelzine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF04	tranylcypromine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF05	iproniazide	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF06	iproclozide	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG	Monoamine oxidase A inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG02	moclobemide	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG03	toloxatone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX	Other antidepressants	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX01	oxitriptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX02	tryptophan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX03	mianserin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX04	nomifensine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX05	trazodone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX06	nefazodone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX07	minaprine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX08	bifemelane	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX09	viloxazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX10	oxaflozane	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX11	mirtazapine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX12	bupropion	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX13	medifoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX14	tianeptine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX15	pivagabine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX16	venlafaxine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX17	milnacipran	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX18	reboxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX19	gepirone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX21	duloxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX22	agomelatine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX23	desvenlafaxine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX24	vilazodone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX25	Hyperici herba	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX26	vortioxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX27	esketamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06B	PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA	Centrally acting sympathomimetics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA01	amfetamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA02	dexamfetamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA03	metamfetamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA04	methylphenidate	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA05	pemoline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA06	fencamfamin	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA07	modafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA08	fenozolone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA09	atomoxetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA10	fenetylline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA11	dexmethylphenidate	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA12	lisdexamfetamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA13	armodafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA14	solriamfetol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC	Xanthine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC01	caffeine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC02	propentofylline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX	Other psychostimulants and nootropics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX01	meclofenoxate	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX02	pyritinol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX03	piracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX04	deanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX05	fipexide	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX06	citicoline	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX07	oxiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX08	pirisudanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX09	linopirdine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX10	nizofenone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX11	aniracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX12	acetylcarnitine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX13	idebenone	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX14	prolintane	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX15	pipradrol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX16	pramiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX17	adrafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX18	vinpocetine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX21	tetramethylglycoluril	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX22	phenibut	WHO Anatomical Therapeutic Chemical classification
0‑L	N06C	PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA	Antidepressants in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA01	amitriptyline and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA02	melitracen and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA03	fluoxetine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CB	Psychostimulants in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	N06D	ANTI-DEMENTIA DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA	Anticholinesterases	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA01	tacrine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA02	donepezil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA03	rivastigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA04	galantamine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA05	ipidacrine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA52	donepezil and memantine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA53	donepezil, memantine and Ginkgo folium	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX	Other anti-dementia drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX01	memantine	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX02	Ginkgo folium	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N07	OTHER NERVOUS SYSTEM DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	N07A	PARASYMPATHOMIMETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA	Anticholinesterases	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA01	neostigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA02	pyridostigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA03	distigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA30	ambenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA51	neostigmine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB	Choline esters	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB01	carbachol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB02	bethanechol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX	Other parasympathomimetics	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX01	pilocarpine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX02	choline alfoscerate	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX03	cevimeline	WHO Anatomical Therapeutic Chemical classification
0‑L	N07B	DRUGS USED IN ADDICTIVE DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA	Drugs used in nicotine dependence	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA01	nicotine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA03	varenicline	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA04	cytisine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB	Drugs used in alcohol dependence	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB01	disulfiram	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB02	calcium carbimide	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB03	acamprosate	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB04	naltrexone	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB05	nalmefene	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC	Drugs used in opioid dependence	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC01	buprenorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC02	methadone	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC03	levacetylmethadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC04	lofexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC05	levomethadone	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC06	diamorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC51	buprenorphine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N07C	ANTIVERTIGO PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA	Antivertigo preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA01	betahistine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA02	cinnarizine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA03	flunarizine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA04	acetylleucine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA52	cinnarizine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	N07X	OTHER NERVOUS SYSTEM DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XA	Gangliosides and ganglioside derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX	Other nervous system drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX01	tirilazad	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX02	riluzole	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX03	xaliproden	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX04	sodium oxybate	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX05	amifampridine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX06	tetrabenazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX07	fampridine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX08	tafamidis	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX10	laquinimod	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX11	pitolisant	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX12	patisiran	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX13	valbenazine	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX14	edaravone	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX15	inotersen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX59	dextromethorphan, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	P01	ANTIPROTOZOALS	WHO Anatomical Therapeutic Chemical classification
0‑L	P01A	AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA	Hydroxyquinoline derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA01	broxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA02	clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA04	chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA05	tilbroquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA52	clioquinol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB	Nitroimidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB01	metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB02	tinidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB03	ornidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB04	azanidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB05	propenidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB06	nimorazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB07	secnidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB51	metronidazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC	Dichloroacetamide derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC01	diloxanide	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC02	clefamide	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC03	etofamide	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC04	teclozan	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR	Arsenic compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR01	arsthinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR02	difetarsone	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR03	glycobiarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR53	glycobiarsol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX	Other agents against amoebiasis and other protozoal diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX01	chiniofon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX02	emetine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX04	phanquinone	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX05	mepacrine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX06	atovaquone	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX07	trimetrexate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX08	tenonitrozole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX09	dehydroemetine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX10	fumagillin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX11	nitazoxanide	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX52	emetine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01B	ANTIMALARIALS	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA	Aminoquinolines	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA01	chloroquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA02	hydroxychloroquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA03	primaquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA06	amodiaquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA07	tafenoquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB	Biguanides	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB01	proguanil	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB02	cycloguanil embonate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB51	proguanil, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC	Methanolquinolines	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC01	quinine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC02	mefloquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD	Diaminopyrimidines	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD01	pyrimethamine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD51	pyrimethamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE	Artemisinin and derivatives, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE01	artemisinin	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE02	artemether	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE03	artesunate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE04	artemotil	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE05	artenimol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF	Artemisinin and derivatives, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF01	artemether and lumefantrine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF02	artesunate and mefloquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF03	artesunate and amodiaquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF04	artesunate, sulfalene and pyrimethamine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF05	artenimol and piperaquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF06	artesunate and pyronaridine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX	Other antimalarials	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX01	halofantrine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX02	arterolane and piperaquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01C	AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA	Nitroimidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA02	benznidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA03	fexinidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB	Antimony compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB01	meglumine antimonate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB02	sodium stibogluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC	Nitrofuran derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC01	nifurtimox	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC02	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD	Arsenic compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD01	melarsoprol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD02	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX	Other agents against leishmaniasis and trypanosomiasis	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX01	pentamidine isethionate	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX02	suramin sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX03	eflornithine	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX04	miltefosine	WHO Anatomical Therapeutic Chemical classification
0‑L	P02	ANTHELMINTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	P02B	ANTITREMATODALS	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA	Quinoline derivatives and related substances	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA01	praziquantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA02	oxamniquine	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BB	Organophosphorous compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BB01	metrifonate	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX	Other antitrematodal agents	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX01	bithionol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX02	niridazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX03	stibophen	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX04	triclabendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02C	ANTINEMATODAL AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA	Benzimidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA01	mebendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA02	tiabendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA03	albendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA04	ciclobendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA05	flubendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA06	fenbendazole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA51	mebendazole, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB	Piperazine and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB01	piperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB02	diethylcarbamazine	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC	Tetrahydropyrimidine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC01	pyrantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC02	oxantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CE	Imidazothiazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CE01	levamisole	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CF	Avermectines	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CF01	ivermectin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX	Other antinematodals	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX01	pyrvinium	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX02	bephenium	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX03	moxidectin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02D	ANTICESTODALS	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DA	Salicylic acid derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DA01	niclosamide	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX	Other anticestodals	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX01	desaspidin	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX02	dichlorophen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03	ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	P03A	ECTOPARASITICIDES, INCL. SCABICIDES	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA	Sulfur containing products	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA01	dixanthogen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA02	potassium polysulfide	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA03	mesulfen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA04	disulfiram	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA05	thiram	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA54	disulfiram, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB	Chlorine containing products	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB01	clofenotane	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB02	lindane	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB51	clofenotane, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC	Pyrethrines, incl. synthetic compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC01	pyrethrum	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC02	bioallethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC03	phenothrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC04	permethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC51	pyrethrum, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC52	bioallethrin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC53	phenothrin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC54	permethrin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX	Other ectoparasiticides, incl. scabicides	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX01	benzyl benzoate	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX02	copper oleinate	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX03	malathion	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX04	quassia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX05	dimeticone	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX06	benzyl alcohol	WHO Anatomical Therapeutic Chemical classification
0‑L	P03B	INSECTICIDES AND REPELLENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA	Pyrethrines	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA01	cyfluthrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA02	cypermethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA03	decamethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA04	tetramethrin	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX	Other insecticides and repellents	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX01	diethyltoluamide	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX02	dimethylphthalate	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX03	dibutylphthalate	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX04	dibutylsuccinate	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX05	dimethylcarbate	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX06	etohexadiol	WHO Anatomical Therapeutic Chemical classification
0‑L	R	RESPIRATORY SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	R01	NASAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA	Sympathomimetics, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA02	cyclopentamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA03	ephedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA04	phenylephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA05	oxymetazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA06	tetryzoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA07	xylometazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA08	naphazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA09	tramazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA10	metizoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA11	tuaminoheptane	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA12	fenoxazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA13	tymazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA14	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA15	indanazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB	Sympathomimetics, combinations excl. corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB01	phenylephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB02	naphazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB03	tetryzoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB05	ephedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB06	xylometazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB07	oxymetazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB08	tuaminoheptane	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC	Antiallergic agents, excl. corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC01	cromoglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC02	levocabastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC03	azelastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC04	antazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC05	spaglumic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC06	thonzylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC07	nedocromil	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC08	olopatadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC51	cromoglicic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD	Corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD01	beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD02	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD03	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD04	flunisolide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD05	budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD06	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD07	tixocortol	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD08	fluticasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD09	mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD11	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD12	fluticasone furoate	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD13	ciclesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD52	prednisolone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD53	dexamethasone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD57	tixocortol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD58	fluticasone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD59	mometasone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD60	hydrocortisone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX	Other nasal preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX01	calcium hexamine thiocyanate	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX02	retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX03	ipratropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX05	ritiometan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX06	mupirocin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX07	hexamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX08	framycetin	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX09	hyaluronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX10	various	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01B	NASAL DECONGESTANTS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA	Sympathomimetics	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA01	phenylpropanolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA02	pseudoephedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA03	phenylephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA51	phenylpropanolamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA52	pseudoephedrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA53	phenylephrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R02	THROAT PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	R02A	THROAT PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA	Antiseptics	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA01	ambazone	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA02	dequalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA03	dichlorobenzyl alcohol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA05	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA06	cetylpyridinium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA09	benzethonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA10	myristyl-benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA11	chlorquinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA12	hexylresorcinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA13	acriflavinium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA14	oxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA15	povidone-iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA16	benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA17	cetrimonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA18	hexamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA19	phenol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA20	various	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA21	octenidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB01	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB02	tyrothricin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB03	fusafungine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB04	bacitracin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB30	gramicidin	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD	Anesthetics, local	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD01	benzocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD02	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD03	cocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD04	dyclonine	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX	Other throat preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX01	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX02	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX03	benzydamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES	WHO Anatomical Therapeutic Chemical classification
0‑L	R03A	ADRENERGICS, INHALANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AA	Alpha- and beta-adrenoreceptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AA01	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB	Non-selective beta-adrenoreceptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB02	isoprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB03	orciprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC	Selective beta-2-adrenoreceptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC02	salbutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC03	terbutaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC04	fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC05	rimiterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC06	hexoprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC07	isoetarine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC08	pirbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC09	tretoquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC10	carbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC11	tulobuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC12	salmeterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC13	formoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC14	clenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC15	reproterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC16	procaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC17	bitolterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC18	indacaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC19	olodaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AH	Combinations of adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK01	epinephrine and other drugs for obstructive airway diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK02	isoprenaline and other drugs for obstructive airway diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK04	salbutamol and sodium cromoglicate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK05	reproterol and sodium cromoglicate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK06	salmeterol and fluticasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK07	formoterol and budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK08	formoterol and beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK09	formoterol and mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK10	vilanterol and fluticasone furoate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK11	formoterol and fluticasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK12	salmeterol and budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK13	salbutamol and beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK14	indacaterol and mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL	Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL01	fenoterol and ipratropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL02	salbutamol and ipratropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL03	vilanterol and umeclidinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL04	indacaterol and glycopyrronium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL05	formoterol and aclidinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL06	olodaterol and tiotropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL07	formoterol and glycopyrronium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL08	vilanterol, umeclidinium bromide and fluticasone furoate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL09	formoterol, glycopyrronium bromide and beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL10	formoterol and tiotropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL11	formoterol, glycopyrronium bromide and budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL12	indacaterol, glycopyrronium bromide and mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03B	OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA	Glucocorticoids	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA01	beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA02	budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA03	flunisolide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA04	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA05	fluticasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA06	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA07	mometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA08	ciclesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA09	fluticasone furoate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB	Anticholinergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB01	ipratropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB02	oxitropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB03	stramoni preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB04	tiotropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB05	aclidinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB06	glycopyrronium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB07	umeclidinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB08	revefenacin	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB54	tiotropium bromide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC	Antiallergic agents, excl. corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC01	cromoglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC03	nedocromil	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BX	Other drugs for obstructive airway diseases, inhalants	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BX01	fenspiride	WHO Anatomical Therapeutic Chemical classification
0‑L	R03C	ADRENERGICS FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CA	Alpha- and beta-adrenoreceptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CA02	ephedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB	Non-selective beta-adrenoreceptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB01	isoprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB02	methoxyphenamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB03	orciprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB51	isoprenaline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB53	orciprenaline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC	Selective beta-2-adrenoreceptor agonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC02	salbutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC03	terbutaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC04	fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC05	hexoprenaline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC06	isoetarine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC07	pirbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC08	procaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC09	tretoquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC10	carbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC11	tulobuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC12	bambuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC13	clenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC14	reproterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC53	terbutaline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC63	clenbuterol and ambroxol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CK	Adrenergics and other drugs for obstructive airway diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	R03D	OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA	Xanthines	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA01	diprophylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA02	choline theophyllinate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA03	proxyphylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA04	theophylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA05	aminophylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA06	etamiphylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA07	theobromine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA08	bamifylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA09	acefylline piperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA10	bufylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA11	doxofylline	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA12	mepyramine theophyllinacetate	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA20	combinations of xanthines	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA51	diprophylline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA54	theophylline, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA55	aminophylline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA57	theobromine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA74	theophylline, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB	Xanthines and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB01	diprophylline and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB02	choline theophyllinate and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB03	proxyphylline and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB04	theophylline and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB05	aminophylline and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB06	etamiphylline and adrenergics	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC	Leukotriene receptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC01	zafirlukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC02	pranlukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC03	montelukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC04	ibudilast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC53	montelukast, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX	Other systemic drugs for obstructive airway diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX01	amlexanox	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX02	eprozinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX03	fenspiride	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX05	omalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX06	seratrodast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX07	roflumilast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX08	reslizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX09	mepolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX10	benralizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R05	COUGH AND COLD PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	R05C	EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA	Expectorants	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA01	tyloxapol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA02	potassium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA03	guaifenesin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA04	ipecacuanha	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA05	althea root	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA06	senega	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA07	antimony pentasulfide	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA08	creosote	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA09	guaiacolsulfonate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA11	levoverbenone	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA12	Hederae helicis folium	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA13	cineole	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB	Mucolytics	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB01	acetylcysteine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB02	bromhexine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB03	carbocisteine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB04	eprazinone	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB05	mesna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB06	ambroxol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB07	sobrerol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB08	domiodol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB09	letosteine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB11	stepronin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB13	dornase alfa (desoxyribonuclease)	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB14	neltenexine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB15	erdosteine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB16	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05D	COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA	Opium alkaloids and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA01	ethylmorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA03	hydrocodone	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA04	codeine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA05	opium alkaloids with morphine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA06	normethadone	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA07	noscapine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA08	pholcodine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA09	dextromethorphan	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA10	thebacon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA11	dimemorfan	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA12	acetyldihydrocodeine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB	Other cough suppressants	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB01	benzonatate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB02	benproperine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB03	clobutinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB04	isoaminile	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB05	pentoxyverine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB07	oxolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB09	oxeladin	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB10	clofedanol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB11	pipazetate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB12	bibenzonium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB13	butamirate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB14	fedrilate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB15	zipeprol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB16	dibunate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB17	droxypropine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB18	prenoxdiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB19	dropropizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB21	cloperastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB22	meprotixol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB23	piperidione	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB24	tipepidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB25	morclofone	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB26	nepinalone	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB27	levodropropizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB28	dimethoxanate	WHO Anatomical Therapeutic Chemical classification
0‑L	R05F	COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA	Opium derivatives and expectorants	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA01	opium derivatives and mucolytics	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA02	opium derivatives and expectorants	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB	Other cough suppressants and expectorants	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB01	cough suppressants and mucolytics	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB02	cough suppressants and expectorants	WHO Anatomical Therapeutic Chemical classification
0‑L	R05X	OTHER COLD PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	R06	ANTIHISTAMINES FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	R06A	ANTIHISTAMINES FOR SYSTEMIC USE	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA	Aminoalkyl ethers	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA01	bromazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA02	diphenhydramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA04	clemastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA06	chlorphenoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA07	diphenylpyraline	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA08	carbinoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA09	doxylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA10	trimethobenzamide	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA52	diphenhydramine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA54	clemastine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA56	chlorphenoxamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA57	diphenylpyraline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA59	doxylamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB	Substituted alkylamines	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB01	brompheniramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB02	dexchlorpheniramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB03	dimetindene	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB04	chlorphenamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB05	pheniramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB06	dexbrompheniramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB07	talastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB51	brompheniramine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB52	dexchlorpheniramine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB54	chlorphenamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB56	dexbrompheniramine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC	Substituted ethylene diamines	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC01	mepyramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC02	histapyrrodine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC03	chloropyramine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC04	tripelennamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC05	methapyrilene	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC06	thonzylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC52	histapyrrodine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC53	chloropyramine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD	Phenothiazine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD01	alimemazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD02	promethazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD03	thiethylperazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD04	methdilazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD05	hydroxyethylpromethazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD06	thiazinam	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD07	mequitazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD08	oxomemazine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD09	isothipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD52	promethazine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD55	hydroxyethylpromethazine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE	Piperazine derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE01	buclizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE03	cyclizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE04	chlorcyclizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE05	meclozine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE06	oxatomide	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE07	cetirizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE09	levocetirizine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE51	buclizine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE53	cyclizine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE55	meclozine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AK	Combinations of antihistamines	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX	Other antihistamines for systemic use	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX01	bamipine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX02	cyproheptadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX03	thenalidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX04	phenindamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX05	antazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX07	triprolidine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX08	pyrrobutamine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX09	azatadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX11	astemizole	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX12	terfenadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX13	loratadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX15	mebhydrolin	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX16	deptropine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX17	ketotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX18	acrivastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX19	azelastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX21	tritoqualine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX22	ebastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX23	pimethixene	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX24	epinastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX25	mizolastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX26	fexofenadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX27	desloratadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX28	rupatadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX29	bilastine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX31	quifenadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX32	sequifenadine	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX53	thenalidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX58	pyrrobutamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R07	OTHER RESPIRATORY SYSTEM PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	R07A	OTHER RESPIRATORY SYSTEM PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA	Lung surfactants	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA01	colfosceril palmitate	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA02	natural phospholipids	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB	Respiratory stimulants	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB01	doxapram	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB02	nikethamide	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB03	pentetrazol	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB04	etamivan	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB05	bemegride	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB06	prethcamide	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB07	almitrine	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB08	dimefline	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB09	mepixanox	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB52	nikethamide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB53	pentetrazol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX	Other respiratory system products	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX01	nitric oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX02	ivacaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX30	ivacaftor and lumacaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX31	ivacaftor and tezacaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX32	ivacaftor, tezacaftor and elexacaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	S	SENSORY ORGANS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01	OPHTHALMOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01A	ANTIINFECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA01	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA02	chlortetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA03	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA04	oxytetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA05	tyrothricin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA07	framycetin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA09	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA10	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA11	gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA12	tobramycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA13	fusidic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA14	benzylpenicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA15	dihydrostreptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA16	rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA17	erythromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA18	polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA19	ampicillin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA20	antibiotics in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA21	amikacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA22	micronomicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA23	netilmicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA24	kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA25	azidamfenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA26	azithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA27	cefuroxime	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA28	vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA30	combinations of different antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB	Sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB01	sulfamethizole	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB02	sulfafurazole	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB03	sulfadicramide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB04	sulfacetamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB05	sulfafenazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD	Antivirals	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD01	idoxuridine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD02	trifluridine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD03	aciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD05	interferon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD06	vidarabine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD07	famciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD08	fomivirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD09	ganciclovir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE	Fluoroquinolones	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE01	ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE02	norfloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE03	ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE04	lomefloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE05	levofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE06	gatifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE07	moxifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE08	besifloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX	Other antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX01	mercury compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX02	silver compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX03	zinc compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX04	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX05	bibrocathol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX06	resorcinol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX07	sodium borate	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX08	hexamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX09	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX10	sodium propionate	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX14	dibrompropamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX15	propamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX16	picloxydine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX18	povidone-iodine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01B	ANTIINFLAMMATORY AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA	Corticosteroids, plain	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA01	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA02	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA03	cortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA04	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA05	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA06	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA07	fluorometholone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA08	medrysone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA09	clobetasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA10	alclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA11	desonide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA12	formocortal	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA13	rimexolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA14	loteprednol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA15	fluocinolone acetonide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB	Corticosteroids and mydriatics in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB01	hydrocortisone and mydriatics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB02	prednisolone and mydriatics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB03	fluorometholone and mydriatics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB04	betamethasone and mydriatics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC	Antiinflammatory agents, non-steroids	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC01	indometacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC02	oxyphenbutazone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC03	diclofenac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC04	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC05	ketorolac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC06	piroxicam	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC07	bendazac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC08	salicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC09	pranoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC10	nepafenac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC11	bromfenac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01C	ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA	Corticosteroids and antiinfectives in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA01	dexamethasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA02	prednisolone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA03	hydrocortisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA04	fluocortolone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA05	betamethasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA06	fludrocortisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA07	fluorometholone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA08	methylprednisolone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA09	chloroprednisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA10	fluocinolone acetonide and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA11	clobetasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB	Corticosteroids/antiinfectives/mydriatics in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB01	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB02	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB03	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB04	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB05	fluorometholone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC	Antiinflammatory agents, non-steroids and antiinfectives in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC01	diclofenac and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC02	indometacin and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA	Sympathomimetics in glaucoma therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA01	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA02	dipivefrine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA03	apraclonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA04	clonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA05	brimonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA51	epinephrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB	Parasympathomimetics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB01	pilocarpine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB02	carbachol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB03	ecothiopate	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB04	demecarium	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB05	physostigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB06	neostigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB07	fluostigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB08	aceclidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB09	acetylcholine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB10	paraoxon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB51	pilocarpine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB58	aceclidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC	Carbonic anhydrase inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC01	acetazolamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC02	diclofenamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC03	dorzolamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC04	brinzolamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC05	methazolamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC54	brinzolamide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED	Beta blocking agents	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED01	timolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED02	betaxolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED03	levobunolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED04	metipranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED05	carteolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED06	befunolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED51	timolol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED52	betaxolol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED54	metipranolol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED55	carteolol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE	Prostaglandin analogues	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE01	latanoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE02	unoprostone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE03	bimatoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE04	travoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE05	tafluprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE06	latanoprostene bunod	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE51	latanoprost and netarsudil	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX	Other antiglaucoma preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX01	guanethidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX02	dapiprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX05	netarsudil	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX06	omidenepag	WHO Anatomical Therapeutic Chemical classification
0‑L	S01F	MYDRIATICS AND CYCLOPLEGICS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA	Anticholinergics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA01	atropine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA02	scopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA03	methylscopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA04	cyclopentolate	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA05	homatropine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA06	tropicamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA54	cyclopentolate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA56	tropicamide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB	Sympathomimetics excl. antiglaucoma preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB01	phenylephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB02	ephedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB03	ibopamine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB51	phenylephrine and ketorolac	WHO Anatomical Therapeutic Chemical classification
0‑L	S01G	DECONGESTANTS AND ANTIALLERGICS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA	Sympathomimetics used as decongestants	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA01	naphazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA02	tetryzoline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA03	xylometazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA04	oxymetazoline	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA05	phenylephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA06	oxedrine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA07	brimonidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA51	naphazoline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA52	tetryzoline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA53	xylometazoline, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA55	phenylephrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA56	oxedrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX	Other antiallergics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX01	cromoglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX02	levocabastine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX03	spaglumic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX04	nedocromil	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX05	lodoxamide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX06	emedastine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX07	azelastine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX08	ketotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX09	olopatadine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX10	epinastine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX11	alcaftadine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX51	cromoglicic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01H	LOCAL ANESTHETICS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA	Local anesthetics	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA01	cocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA02	oxybuprocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA03	tetracaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA04	proxymetacaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA05	procaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA06	cinchocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA07	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01J	DIAGNOSTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA	Colouring agents	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA01	fluorescein	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA02	rose bengal sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA51	fluorescein, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JX	Other ophthalmological diagnostic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	S01K	SURGICAL AIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA	Viscoelastic substances	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA01	hyaluronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA02	hypromellose	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA51	hyaluronic acid, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX	Other surgical aids	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX01	chymotrypsin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01L	OCULAR VASCULAR DISORDER AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA	Antineovascularisation agents	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA01	verteporfin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA02	anecortave	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA03	pegaptanib	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA04	ranibizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA05	aflibercept	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA06	brolucizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA07	abicipar pegol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01X	OTHER OPHTHALMOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA	Other ophthalmologicals	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA01	guaiazulen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA02	retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA03	sodium chloride, hypertonic	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA04	potassium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA05	sodium edetate	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA06	ethylmorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA07	alum	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA08	acetylcysteine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA09	iodoheparinate	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA10	inosine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA11	nandrolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA12	dexpanthenol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA13	alteplase	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA14	heparin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA15	ascorbic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA18	ciclosporin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA19	limbal stem cells, autologous	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA20	artificial tears and other indifferent preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA21	mercaptamine	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA22	ocriplasmin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA23	sirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA24	cenegermin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA25	lifitegrast	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA26	riboflavin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA27	voretigene neparvovec	WHO Anatomical Therapeutic Chemical classification
0‑L	S02	OTOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	S02A	ANTIINFECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA	Antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA01	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA02	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA03	boric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA04	aluminium acetotartrate	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA05	clioquinol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA06	hydrogen peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA07	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA08	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA09	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA10	acetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA11	polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA12	rifamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA13	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA14	gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA15	ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA16	ofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA30	antiinfectives, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S02B	CORTICOSTEROIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA	Corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA01	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA03	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA06	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA07	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA08	fluocinolone acetonide	WHO Anatomical Therapeutic Chemical classification
0‑L	S02C	CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA	Corticosteroids and antiinfectives in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA01	prednisolone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA02	flumetasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA03	hydrocortisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA04	triamcinolone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA05	fluocinolone acetonide and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA06	dexamethasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA07	fludrocortisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S02D	OTHER OTOLOGICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA	Analgesics and anesthetics	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA01	lidocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA02	cocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA03	phenazone	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA04	cinchocaine	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DC	Indifferent preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	S03	OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	S03A	ANTIINFECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA	Antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA01	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA02	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA03	polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA04	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA05	hexamidine	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA06	gentamicin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA07	ciprofloxacin	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA08	chloramphenicol	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA30	antiinfectives, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	S03B	CORTICOSTEROIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA	Corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA01	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA02	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA03	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	S03C	CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA	Corticosteroids and antiinfectives in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA01	dexamethasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA02	prednisolone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA04	hydrocortisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA05	fludrocortisone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA06	betamethasone and antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	S03D	OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	V	VARIOUS	WHO Anatomical Therapeutic Chemical classification
0‑L	V01	ALLERGENS	WHO Anatomical Therapeutic Chemical classification
0‑L	V01A	ALLERGENS	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA	Allergen extracts	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA01	feather	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA02	grass pollen	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA03	house dust mites	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA04	mould fungus and yeast fungus	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA05	tree pollen	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA07	insects	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA08	food	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA09	textiles	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA10	flowers	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA11	animals	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA20	various	WHO Anatomical Therapeutic Chemical classification
0‑L	V03	ALL OTHER THERAPEUTIC PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V03A	ALL OTHER THERAPEUTIC PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB	Antidotes	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB01	ipecacuanha	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB02	nalorphine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB03	edetates	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB04	pralidoxime	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB05	prednisolone and promethazine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB06	thiosulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB08	sodium nitrite	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB09	dimercaprol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB13	obidoxime	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB14	protamine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB15	naloxone	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB16	ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB17	methylthioninium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB18	potassium permanganate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB19	physostigmine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB20	copper sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB21	potassium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB22	amyl nitrite	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB23	acetylcysteine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB24	digitalis antitoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB25	flumazenil	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB26	methionine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB27	4-dimethylaminophenol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB29	cholinesterase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB31	prussian blue	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB32	glutathione	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB33	hydroxocobalamin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB34	fomepizole	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB35	sugammadex	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB36	phentolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB37	idarucizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB38	andexanet alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC	Iron chelating agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC01	deferoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC02	deferiprone	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC03	deferasirox	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE	Drugs for treatment of hyperkalemia and hyperphosphatemia	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE01	polystyrene sulfonate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE02	sevelamer	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE03	lanthanum carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE04	calcium acetate and magnesium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE05	sucroferric oxyhydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE06	colestilan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE07	calcium acetate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE08	ferric citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE09	patiromer calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE10	sodium zirconium cyclosilicate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF	Detoxifying agents for antineoplastic treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF01	mesna	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF02	dexrazoxane	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF03	calcium folinate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF04	calcium levofolinate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF05	amifostine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF06	sodium folinate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF07	rasburicase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF08	palifermin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF09	glucarpidase	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF10	sodium levofolinate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF11	arginine and lysine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG	Drugs for treatment of hypercalcemia	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG01	sodium cellulose phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AH	Drugs for treatment of hypoglycemia	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AH01	diazoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AK	Tissue adhesives	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AM	Drugs for embolisation	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN	Medical gases	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN01	oxygen	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN02	carbon dioxide	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN03	helium	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN04	nitrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN05	medical air	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX	Other therapeutic products	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX02	nalfurafine	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX03	cobicistat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AZ	Nerve depressants	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AZ01	ethanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04	DIAGNOSTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V04B	URINE TESTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V04C	OTHER DIAGNOSTIC AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA	Tests for diabetes	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA01	tolbutamide	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA02	glucose	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CB	Tests for fat absorption	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CB01	vitamin A concentrates	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC	Tests for bile duct patency	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC01	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC02	magnesium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC03	sincalide	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC04	ceruletide	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD	Tests for pituitary function	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD01	metyrapone	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD03	sermorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD04	corticorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD05	somatorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD06	macimorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE	Tests for liver functional capacity	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE01	galactose	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE02	sulfobromophthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE03	methacetin (13C)	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CF	Tuberculosis diagnostics	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CF01	tuberculin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG	Tests for gastric secretion	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG01	cation exchange resins	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG02	betazole	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG03	histamine phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG04	pentagastrin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG05	methylthioninium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG30	caffeine and sodium benzoate	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH	Tests for renal function and ureteral injuries	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH01	inulin and other polyfructosans	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH02	indigo carmine	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH03	phenolsulfonphthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH04	alsactide	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH30	aminohippuric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ	Tests for thyreoidea function	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ01	thyrotropin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ02	protirelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK	Tests for pancreatic function	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK01	secretin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK02	pancreozymin (cholecystokinin)	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK03	bentiromide	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CL	Tests for allergic diseases	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CM	Tests for fertility disturbances	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CM01	gonadorelin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX	Other diagnostic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX01	indocyanine green	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX02	folic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX03	methacholine	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX04	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX05	13C-urea	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX06	hexaminolevulinate	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX07	edrophonium	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX08	carbon monoxide	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX09	patent blue	WHO Anatomical Therapeutic Chemical classification
0‑L	V06	GENERAL NUTRIENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V06A	DIET FORMULATIONS FOR TREATMENT OF OBESITY	WHO Anatomical Therapeutic Chemical classification
0‑L	V06AA	Low-energy diets	WHO Anatomical Therapeutic Chemical classification
0‑L	V06B	PROTEIN SUPPLEMENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V06C	INFANT FORMULAS	WHO Anatomical Therapeutic Chemical classification
0‑L	V06CA	Nutrients without phenylalanine	WHO Anatomical Therapeutic Chemical classification
0‑L	V06D	OTHER NUTRIENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DA	Carbohydrates/proteins/minerals/vitamins, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DB	Fat/carbohydrates/proteins/minerals/vitamins, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC	Carbohydrates	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC01	glucose	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC02	fructose	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DD	Amino acids, incl. combinations with polypeptides	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DE	Amino acids/carbohydrates/minerals/vitamins, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DF	Milk substitutes	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DX	Other combinations of nutrients	WHO Anatomical Therapeutic Chemical classification
0‑L	V07	ALL OTHER NON-THERAPEUTIC PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V07A	ALL OTHER NON-THERAPEUTIC PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AA	Plasters	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AB	Solvents and diluting agents, incl. irrigating solutions	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AC	Blood transfusion, auxiliary products	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AD	Blood tests, auxiliary products	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AN	Incontinence equipment	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AR	Sensitivity tests, discs and tablets	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AS	Stomi equipment	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AT	Cosmetics	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AV	Technical disinfectants	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AX	Washing agents etc.	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AY	Other non-therapeutic auxiliary products	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AZ	Chemicals and reagents for analysis	WHO Anatomical Therapeutic Chemical classification
0‑L	V08	CONTRAST MEDIA	WHO Anatomical Therapeutic Chemical classification
0‑L	V08A	X-RAY CONTRAST MEDIA, IODINATED	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA	Watersoluble, nephrotropic, high osmolar X-ray contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA01	diatrizoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA02	metrizoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA03	iodamide	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA04	iotalamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA05	ioxitalamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA06	ioglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA07	acetrizoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA08	iocarmic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA09	methiodal	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA10	diodone	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB	Watersoluble, nephrotropic, low osmolar X-ray contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB01	metrizamide	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB02	iohexol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB03	ioxaglic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB04	iopamidol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB05	iopromide	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB06	iotrolan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB07	ioversol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB08	iopentol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB09	iodixanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB10	iomeprol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB11	iobitridol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB12	ioxilan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC	Watersoluble, hepatotropic X-ray contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC01	iodoxamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC02	iotroxic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC03	ioglycamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC04	adipiodone	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC05	iobenzamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC06	iopanoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC07	iocetamic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC08	sodium iopodate	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC09	tyropanoic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC10	calcium iopodate	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD	Non-watersoluble X-ray contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD01	ethyl esters of iodised fatty acids	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD02	iopydol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD03	propyliodone	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD04	iofendylate	WHO Anatomical Therapeutic Chemical classification
0‑L	V08B	X-RAY CONTRAST MEDIA, NON-IODINATED	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA	Barium sulfate containing X-ray contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA01	barium sulfate with suspending agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA02	barium sulfate without suspending agents	WHO Anatomical Therapeutic Chemical classification
0‑L	V08C	MAGNETIC RESONANCE IMAGING CONTRAST MEDIA	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA	Paramagnetic contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA01	gadopentetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA02	gadoteric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA03	gadodiamide	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA04	gadoteridol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA05	mangafodipir	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA06	gadoversetamide	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA07	ferric ammonium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA08	gadobenic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA09	gadobutrol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA10	gadoxetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA11	gadofosveset	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB	Superparamagnetic contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB01	ferumoxsil	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB02	ferristene	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB03	iron oxide, nanoparticles	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CX	Other magnetic resonance imaging contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CX01	perflubron	WHO Anatomical Therapeutic Chemical classification
0‑L	V08D	ULTRASOUND CONTRAST MEDIA	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA	Ultrasound contrast media	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA01	perflutren, human albumin microspheres	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA02	microparticles of galactose	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA03	perflenapent	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA04	perflutren, phospholipid microspheres	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA05	sulfur hexafluoride, phospholipid microspheres	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA06	perflubutane, phospholipid microspheres	WHO Anatomical Therapeutic Chemical classification
0‑L	V09	DIAGNOSTIC RADIOPHARMACEUTICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	V09A	CENTRAL NERVOUS SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA01	technetium (99mTc) exametazime	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA02	technetium (99mTc) bicisate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB	Iodine (123I) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB01	iodine iofetamine (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB02	iodine iolopride (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB03	iodine ioflupane (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX	Other central nervous system diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX01	indium (111In) pentetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX03	iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX04	flutemetamol (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX05	florbetapir (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX06	florbetaben (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09B	SKELETON	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA01	technetium (99mTc) oxidronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA02	technetium (99mTc) medronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA03	technetium (99mTc) pyrophosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA04	technetium (99mTc) butedronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09C	RENAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA01	technetium (99mTc) pentetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA02	technetium (99mTc) succimer	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA03	technetium (99mTc) mertiatide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA04	technetium (99mTc) gluceptate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA05	technetium (99mTc) gluconate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA06	technetium (99mTc) ethylenedicysteine	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX	Other renal system diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX01	sodium iodohippurate (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX02	sodium iodohippurate (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX03	sodium iothalamate (125I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX04	chromium (51Cr) edetate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09D	HEPATIC AND RETICULO ENDOTHELIAL SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA01	technetium (99mTc) disofenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA02	technetium (99mTc) etifenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA03	technetium (99mTc) lidofenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA04	technetium (99mTc) mebrofenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA05	technetium (99mTc) galtifenin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB	Technetium (99mTc), particles and colloids	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB01	technetium (99mTc) nanocolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB02	technetium (99mTc) microcolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB03	technetium (99mTc) millimicrospheres	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB04	technetium (99mTc) tin colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB05	technetium (99mTc) sulfur colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB06	technetium (99mTc) rheniumsulfide colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB07	technetium (99mTc) phytate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DX	Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DX01	selenium (75Se) tauroselcholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09E	RESPIRATORY SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA	Technetium (99mTc), inhalants	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA01	technetium (99mTc) pentetic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA02	technetium (99mTc) technegas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA03	technetium (99mTc) nanocolloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB	Technetium (99mTc), particles for injection	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB01	technetium (99mTc) macrosalb	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB02	technetium (99mTc) microspheres	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX	Other respiratory system diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX01	krypton (81mKr) gas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX02	xenon (127Xe) gas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX03	xenon (133Xe) gas	WHO Anatomical Therapeutic Chemical classification
0‑L	V09F	THYROID	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX	Various thyroid diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX01	technetium (99mTc) pertechnetate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX02	sodium iodide (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX03	sodium iodide (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX04	sodium iodide (124I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09G	CARDIOVASCULAR SYSTEM	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA01	technetium (99mTc) sestamibi	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA02	technetium (99mTc) tetrofosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA03	technetium (99mTc) teboroxime	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA04	technetium (99mTc) human albumin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA05	technetium (99mTc) furifosmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA06	technetium (99mTc) stannous agent labelled cells	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA07	technetium (99mTc) apcitide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB	Iodine (125I) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB01	fibrinogen (125I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB02	iodine (125I) human albumin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX	Other cardiovascular system diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX01	thallium (201Tl) chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX02	indium (111In) imciromab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX03	chromium (51Cr) chromate labelled cells	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX04	rubidium (82Rb) chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	V09H	INFLAMMATION AND INFECTION DETECTION	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA01	technetium (99mTc) human immunoglobulin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA02	technetium (99mTc) exametazime labelled cells	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA03	technetium (99mTc) antigranulocyte antibody	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA04	technetium (99mTc) sulesomab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB	Indium (111In) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB01	indium (111In) oxinate labelled cells	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB02	indium (111In) tropolonate labelled cells	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HX	Other diagnostic radiopharmaceuticals for inflammation and infection detection	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HX01	gallium (67Ga) citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	V09I	TUMOUR DETECTION	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA	Technetium (99mTc) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA01	technetium (99mTc) antiCarcinoEmbryonicAntigen antibody	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA02	technetium (99mTc) antimelanoma antibody	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA03	technetium (99mTc) pentavalent succimer	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA04	technetium (99mTc) votumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA05	technetium (99mTc) depreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA06	technetium (99mTc) arcitumomab	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA07	technetium (99mTc) hynic-octreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA08	technetium (99mTc) etarfolatide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA09	technetium (99mTc) tilmanocept	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB	Indium (111In) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB01	indium (111In) pentetreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB02	indium (111In) satumomab pendetide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB03	indium (111In) antiovariumcarcinoma antibody	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB04	indium (111In) capromab pendetide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX	Other diagnostic radiopharmaceuticals for tumour detection	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX01	iobenguane (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX02	iobenguane (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX03	iodine (125I) CC49-monoclonal antibody	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX04	fludeoxyglucose (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX05	fluorodopa (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX06	sodium fluoride (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX07	fluorocholine(18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX08	fluoroethylcholine (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX09	gallium (68Ga) edotreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX10	fluoroethyl-L-tyrosine (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX11	fluoroestradiol (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX12	fluciclovine (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX13	methionine (11C)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09X	OTHER DIAGNOSTIC RADIOPHARMACEUTICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA	Iodine (131I) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA01	iodine (131I) norcholesterol	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA02	iodocholesterol (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA03	iodine (131I) human albumin	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX	Various diagnostic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX01	cobalt (57Co) cyanocobalamine	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX02	cobalt (58Co) cyanocobalamine	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX03	selenium (75Se) norcholesterol	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX04	ferric (59Fe) citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	V10	THERAPEUTIC RADIOPHARMACEUTICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	V10A	ANTIINFLAMMATORY AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA	Yttrium (90Y) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA01	yttrium (90Y) citrate colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA02	yttrium (90Y) ferrihydroxide colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA03	yttrium (90Y) silicate colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX	Other antiinflammatory therapeutic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX01	phosphorous (32P) chromicphosphate colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX02	samarium (153Sm) hydroxyapatite colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX03	dysprosium (165Dy) colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX04	erbium (169Er) citrate colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX05	rhenium (186Re) sulfide colloid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX06	gold (198Au) colloidal	WHO Anatomical Therapeutic Chemical classification
0‑L	V10B	PAIN PALLIATION (BONE SEEKING AGENTS)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX	Various pain palliation radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX01	strontium (89Sr) chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX02	samarium (153Sm) lexidronam	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX03	rhenium (186Re) etidronic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	V10X	OTHER THERAPEUTIC RADIOPHARMACEUTICALS	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA	Iodine (131I) compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA01	sodium iodide (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA02	iobenguane (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA53	tositumomab/iodine (131I) tositumomab	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX	Various therapeutic radiopharmaceuticals	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX01	sodium phosphate (32P)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX02	ibritumomab tiuxetan (90Y)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX03	radium (223Ra) dichloride	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX04	lutetium (177Lu) oxodotreotide	WHO Anatomical Therapeutic Chemical classification
0‑L	V20	SURGICAL DRESSINGS	WHO Anatomical Therapeutic Chemical classification

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.

XML JSON CSV SQL SVS

Value Set
Show index

Value Set

Value Set eHDSIActiveIngredient 2021‑04‑19 15:45:00